| 1 |
Weiner A, Turjeman S, Koren O. Gut microbes and host behavior: The forgotten members of the gut-microbiome. Neuropharmacology 2023;227:109453. [PMID: 36738776 DOI: 10.1016/j.neuropharm.2023.109453] [Reference Citation Analysis]
|
| 2 |
Silverstein MR, Segrè D, Bhatnagar JM. Environmental microbiome engineering for the mitigation of climate change. Glob Chang Biol 2023;29:2050-66. [PMID: 36661406 DOI: 10.1111/gcb.16609] [Reference Citation Analysis]
|
| 3 |
Boicean A, Birlutiu V, Ichim C, Anderco P, Birsan S. Fecal Microbiota Transplantation in Inflammatory Bowel Disease. Biomedicines 2023;11:1016. [DOI: 10.3390/biomedicines11041016] [Reference Citation Analysis]
|
| 4 |
Cyriac Abby Philips. “Seek and find” or “search and destroy?” Identifying and retaining “healthy” stool donors for fecal microbiota transplantation. JGH Open 2023;7. [ DOI: 10.1002/jgh3.12892] [Reference Citation Analysis]
|
| 5 |
Stoff R, Wolf Y, Boursi B. Fecal Microbiota Transplantation as a Cancer Therapeutic. Cancer J 2023;29:102-8. [PMID: 36957981 DOI: 10.1097/PPO.0000000000000651] [Reference Citation Analysis]
|
| 6 |
Attebury H, Daley D. The Gut Microbiome and Pancreatic Cancer Development and Treatment. Cancer J 2023;29:49-56. [PMID: 36957973 DOI: 10.1097/PPO.0000000000000647] [Reference Citation Analysis]
|
| 7 |
Mascolo A, Carannante N, Mauro GD, Sarno M, Costanzo M, Licciardi F, Bernardo M, Capoluongo N, Perrella A, Capuano A. Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature. J Infect Public Health 2023;16:376-83. [PMID: 36702012 DOI: 10.1016/j.jiph.2023.01.009] [Reference Citation Analysis]
|
| 8 |
Gulati AS, Nicholson MR, Khoruts A, Kahn SA. Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation. Am J Gastroenterol 2023;118:435-9. [PMID: 36580630 DOI: 10.14309/ajg.0000000000002167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Alonzo-De la Rosa CM, Miard S, Taubert S, Picard F. Methods to extract and study the biological effects of murine gut microbiota using Caenorhabditis elegans as a screening host. PLoS One 2023;18:e0281887. [PMID: 36821579 DOI: 10.1371/journal.pone.0281887] [Reference Citation Analysis]
|
| 10 |
Mahmoudi H, Hossainpour H. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review. Saudi J Gastroenterol 2023;29:3-11. [PMID: 36412458 DOI: 10.4103/sjg.sjg_131_22] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Cheng YW, Fischer M. Fecal Microbiota Transplantation. Clin Colon Rectal Surg 2023;36:151-6. [PMID: 36844708 DOI: 10.1055/s-0043-1760865] [Reference Citation Analysis]
|
| 12 |
Hao S, Yang S, Zhang N, Cheng H. Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends. Can J Infect Dis Med Microbiol 2023;2023:6981721. [PMID: 36654766 DOI: 10.1155/2023/6981721] [Reference Citation Analysis]
|
| 13 |
Vasiliu O. Is fecal microbiota transplantation a useful therapeutic intervention for psychiatric disorders? A narrative review of clinical and preclinical evidence. Curr Med Res Opin 2023;39:161-77. [PMID: 36094098 DOI: 10.1080/03007995.2022.2124071] [Reference Citation Analysis]
|
| 14 |
Yousefi B, Babaeizad A, Banihashemian SZ, Feyzabadi ZK, Dadashpour M, Pahlevan D, Ghaffari H, Eslami M. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS. Curr Microbiol 2023;80:38. [DOI: 10.1007/s00284-022-03150-7] [Reference Citation Analysis]
|
| 15 |
Ruissen M, Keller J, Tushuizen ME. Fecal transplant. Visceral and Ectopic Fat 2023. [DOI: 10.1016/b978-0-12-822186-0.00010-9] [Reference Citation Analysis]
|
| 16 |
Tkach S, Dorofeyev A, Kuzenko I, Boyko N, Falalyeyeva T, Kobyliak N. Fecal Microbiota Transplantation in Diseases Not Associated with Clostridium difficile: Current Status and Future Therapeutic Option. Microbiome in 3P Medicine Strategies 2023. [DOI: 10.1007/978-3-031-19564-8_10] [Reference Citation Analysis]
|
| 17 |
Alaoui Mdarhri H, Benmessaoud R, Yacoubi H, Seffar L, Guennouni Assimi H, Hamam M, Boussettine R, Filali-Ansari N, Lahlou FA, Diawara I, Ennaji MM, Kettani-Halabi M. Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine. Antibiotics (Basel) 2022;11. [PMID: 36551487 DOI: 10.3390/antibiotics11121826] [Reference Citation Analysis]
|
| 18 |
Lewandowska-Pietruszka Z, Figlerowicz M, Mazur-Melewska K. The History of the Intestinal Microbiota and the Gut-Brain Axis. Pathogens 2022;11. [PMID: 36558874 DOI: 10.3390/pathogens11121540] [Reference Citation Analysis]
|
| 19 |
Gu X, Chen ZH, Zhang SC. Fecal microbiota transplantation in childhood: past, present, and future. World J Pediatr 2022;:1-10. [PMID: 36484871 DOI: 10.1007/s12519-022-00655-w] [Reference Citation Analysis]
|
| 20 |
Quaranta G, Guarnaccia A, Fancello G, Agrillo C, Iannarelli F, Sanguinetti M, Masucci L. Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies. Microorganisms 2022;10. [PMID: 36557677 DOI: 10.3390/microorganisms10122424] [Reference Citation Analysis]
|
| 21 |
Willman J, Willman M, Reddy R, Fusco A, Sriram S, Mehkri Y, Charles J, Goeckeritz J, Lucke-Wold B. Gut microbiome and neurosurgery: Implications for treatment. Clin Transl Discov 2022;2:e139. [PMID: 36268259 DOI: 10.1002/ctd2.139] [Reference Citation Analysis]
|
| 22 |
Ma Y, Ke D, Li D, Zhang Q. Donors' experiences and attitudes of fecal microbiota transplantation: An empirical bioethics study from China. iMeta 2022. [DOI: 10.1002/imt2.62] [Reference Citation Analysis]
|
| 23 |
Elokil AA, Chen W, Mahrose K, Elattrouny MM, Abouelezz KFM, Ahmad HI, Liu H, Elolimy AA, Mandouh MI, Abdelatty AM, Li S. Early life microbiota transplantation from highly feed-efficient broiler improved weight gain by reshaping the gut microbiota in laying chicken. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.1022783] [Reference Citation Analysis]
|
| 24 |
Yang J, Deng Y, Cai Y, Liu Y, Peng L, Luo Z, Li D. Mapping trends and hotspot regarding gastrointestinal microbiome and neuroscience: A bibliometric analysis of global research (2002–2022). Front Neurosci 2022;16. [DOI: 10.3389/fnins.2022.1048565] [Reference Citation Analysis]
|
| 25 |
Li Y, Ouyang Y, He C. Research trends on clinical fecal microbiota transplantation: A biliometric analysis from 2001 to 2021. Front Immunol 2022;13:991788. [DOI: 10.3389/fimmu.2022.991788] [Reference Citation Analysis]
|
| 26 |
Phizackerley D. Therapeutic value of human faeces. DTB 2022. [DOI: 10.1136/dtb.2022.000056] [Reference Citation Analysis]
|
| 27 |
Wang Y, Zhang S, Borody TJ, Zhang F. Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases. Chinese Medical Journal 2022;Publish Ahead of Print. [DOI: 10.1097/cm9.0000000000002339] [Reference Citation Analysis]
|
| 28 |
Xu H, Cao C, Ren Y, Weng S, Liu L, Guo C, Wang L, Han X, Ren J, Liu Z. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment. Front Immunol 2022;13:949490. [DOI: 10.3389/fimmu.2022.949490] [Reference Citation Analysis]
|
| 29 |
Qu Z, Tian P, Yang B, Zhao J, Wang G, Chen W. Fecal microbiota transplantation for diseases: Therapeutic potential, methodology, risk management in clinical practice. Life Sciences 2022;304:120719. [DOI: 10.1016/j.lfs.2022.120719] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 30 |
Wang M, Xie X, Zhao S, Han W, Zhang Y. Global research trends and hotspots of fecal microbiota transplantation: A bibliometric and visualization study. Front Microbiol 2022;13:990800. [DOI: 10.3389/fmicb.2022.990800] [Reference Citation Analysis]
|
| 31 |
van der Vossen EWJ, de Goffau MC, Levin E, Nieuwdorp M. Recent insights into the role of microbiome in the pathogenesis of obesity. Therap Adv Gastroenterol 2022;15:17562848221115320. [PMID: 35967920 DOI: 10.1177/17562848221115320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Biazzo M, Deidda G. Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases. J Clin Med 2022;11:4119. [PMID: 35887883 DOI: 10.3390/jcm11144119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 33 |
Li Q, Zhou S, Wang Y, Cong J. Changes of intestinal microbiota and microbiota-based treatments in IBD. Arch Microbiol 2022;204:442. [PMID: 35776212 DOI: 10.1007/s00203-022-03069-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 35 |
Huang W, Huang H, Peng W, Liu Y, Zhou Y, Xu H, Zhang L, Zhao C, Nie Y. Altered Pattern of Immunoglobulin A-Targeted Microbiota in Inflammatory Bowel Disease After Fecal Transplantation. Front Microbiol 2022;13:873018. [DOI: 10.3389/fmicb.2022.873018] [Reference Citation Analysis]
|
| 36 |
Bi T, Zhang L, Zhan L, Feng R, Zhao T, Ren W, Hang T, Zhou W, Lu X. Integrated Analyses of Microbiomics and Metabolomics Explore the Effect of Gut Microbiota Transplantation on Diabetes-Associated Cognitive Decline in Zucker Diabetic Fatty Rats. Front Aging Neurosci 2022;14:913002. [DOI: 10.3389/fnagi.2022.913002] [Reference Citation Analysis]
|
| 37 |
Sundaramoorthy NS, Shankaran P, Gopalan V, Nagarajan S. New tools to mitigate drug resistance in Enterobacteriaceae - Escherichia coli and Klebsiella pneumoniae. Crit Rev Microbiol 2022;:1-20. [PMID: 35649163 DOI: 10.1080/1040841X.2022.2080525] [Reference Citation Analysis]
|
| 38 |
Lu G, Zhang F. The levels and core delivery ways of gut microbial reconstruction. Sci Sin -Vitae 2022. [DOI: 10.1360/ssv-2021-0381] [Reference Citation Analysis]
|
| 39 |
Wu L, Bao F, Li L, Yin X, Hua Z. Bacterially mediated drug delivery and therapeutics: strategies and advancements. Adv Drug Deliv Rev 2022;:114363. [PMID: 35649449 DOI: 10.1016/j.addr.2022.114363] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 40 |
Nabizadeh E, Sadeghi J, Ahangarzadeh Rezaee M, Hasani A, Samadi Kafil H, Ghotaslou A, Kadkhoda H, Ghotaslou R. Interaction Between Altered Gut Microbiota and Sepsis: A Hypothesis or an Authentic Fact? J Intensive Care Med. [DOI: 10.1177/08850666221102796] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 41 |
Jiang Y, Wang S, Wang Y, Zhang X, Li S. A framework to trace microbial engraftment at the strain level during fecal microbiota transplantation.. [DOI: 10.1101/2022.05.18.492592] [Reference Citation Analysis]
|
| 42 |
Lu G, Wang W, Li P, Wen Q, Cui B, Zhang F. Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Microb Biotechnol 2022. [PMID: 35576458 DOI: 10.1111/1751-7915.14074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 43 |
Zhang Y, Saint Fleur A, Feng H. The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota. Gut Microbes 2022;14:2052698. [PMID: 35319337 DOI: 10.1080/19490976.2022.2052698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Joachim A, Schwerd T, Hölz H, Sokollik C, Konrad LA, Jordan A, Lanzersdorfer R, Schmidt-Choudhury A, Hünseler C, Adam R. [Fecal Microbiota Transfer (FMT) in Children and Adolescents - Review and statement by the GPGE microbiome working group]. Z Gastroenterol 2022. [PMID: 35533688 DOI: 10.1055/a-1801-0284] [Reference Citation Analysis]
|
| 45 |
Gasmi A, Bjørklund G, Mujawdiya PK, Semenova Y, Dosa A, Piscopo S, Pen JJ, Gasmi Benahmed A, Costea DO. Gut microbiota in bariatric surgery. Crit Rev Food Sci Nutr 2022;:1-16. [PMID: 35531940 DOI: 10.1080/10408398.2022.2067116] [Reference Citation Analysis]
|
| 46 |
Kinoshita Y, Niwa H, Uchida-fujii E, Nukada T, Ueno T. Simultaneous daily fecal microbiota transplantation fails to prevent metronidazole-induced dysbiosis of equine gut microbiota. Journal of Equine Veterinary Science 2022. [DOI: 10.1016/j.jevs.2022.104004] [Reference Citation Analysis]
|
| 47 |
Shang L, Tu J, Dai Z, Zeng X, Qiao S. Microbiota Transplantation in an Antibiotic-Induced Bacterial Depletion Mouse Model: Reproducible Establishment, Analysis, and Application. Microorganisms 2022;10:902. [PMID: 35630347 DOI: 10.3390/microorganisms10050902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 48 |
Ferguson L, Barnett M. Nutrigenomics and Nutrigenetics Research in New Zealand, and Its Relevance and Application to Gastrointestinal Health. Nutrients 2022;14:1743. [DOI: 10.3390/nu14091743] [Reference Citation Analysis]
|
| 49 |
Řehořová V, Cibulková I, Soukupová H, Duška F. Multi-Donor Fecal Microbial Transplantation for Critically Ill Patients: Rationale and Standard Operating Procedure. Future Pharmacology 2022;2:55-63. [DOI: 10.3390/futurepharmacol2010005] [Reference Citation Analysis]
|
| 50 |
DeVine MN, MacBrayne CE, Child J, Blackmer AB. Pharmacological Management of Pediatric Clostridioides difficile Infection: Clarifying the Controversies. J Pediatr Health Care 2022;36:181-92. [PMID: 34412953 DOI: 10.1016/j.pedhc.2021.06.005] [Reference Citation Analysis]
|
| 51 |
Zhang S, Chen Q, Kelly CR, Kassam Z, Qin H, Li N, Tian H, Yang B, Zhao D, Ye C, Lin Z, Cui J, Zhou S, Chen X, Lv X, Yang R; Shanghai Tongji FMT Working Group. Donor Screening for Fecal Microbiota Transplantation in China: Evaluation of 8483 Candidates. Gastroenterology 2022;162:966-968.e3. [PMID: 34752816 DOI: 10.1053/j.gastro.2021.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 52 |
Chen Y, Xueying Z, Jiaqu C, Qiyi C, Huanlong Q, Ning L, Yasong D, Xiaoxin Z, Rong Y, Jubao L, Xiaoqiong L, Chunlian M, Yu W, Shidong C, Guifang K, Dongmei Z, Shuanfeng F, Xujing Z, Binrang Y, Yanxia W, Ling L, Song Y, Xiang Z, Beihua Z, Lin J, Hong J; FTACMT Working Group. FTACMT study protocol: a multicentre, double-blind, randomised, placebo-controlled trial of faecal microbiota transplantation for autism spectrum disorder. BMJ Open 2022;12:e051613. [PMID: 35105621 DOI: 10.1136/bmjopen-2021-051613] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 53 |
Tkach S, Dorofeyev A, Kuzenko I, Boyko N, Falalyeyeva T, Boccuto L, Scarpellini E, Kobyliak N, Abenavoli L. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation. Medicina (Kaunas) 2022;58:84. [PMID: 35056392 DOI: 10.3390/medicina58010084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 54 |
Tsigalou C, Konstantinidis T, Aloizou A, Bezirtzoglou E, Tsakris A. Future Therapeutic Prospects in Dealing with Autoimmune Diseases: Treatment Based on the Microbiome Model. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-4800-8_25] [Reference Citation Analysis]
|
| 55 |
Radhakrishanan A, Kakkar P, Tandon C, Srivastav R. Fecal Microbiome Transplantation: An Offhand Recipe for Microbiome Therapeutics. Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00001-2] [Reference Citation Analysis]
|
| 56 |
Junca H, Pieper DH, Medina E. The emerging potential of microbiome transplantation on human health interventions. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.01.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 57 |
Shah F, Dwivedi M. Pathophysiological Role of Gut Microbiota Affecting Gut–Brain Axis and Intervention of Probiotics and Prebiotics in Autism Spectrum Disorder. Probiotic Research in Therapeutics 2022. [DOI: 10.1007/978-981-16-6760-2_4] [Reference Citation Analysis]
|
| 58 |
Mehrotra T, Maulik SK. Hepatic drug metabolism and gut microbiome. Progress in Molecular Biology and Translational Science 2022. [DOI: 10.1016/bs.pmbts.2022.07.005] [Reference Citation Analysis]
|
| 59 |
Requena T, Pérez Martínez G. Probiotics, Prebiotics, Synbiotics, Postbiotics and Other Biotics. What's Next? Comprehensive Gut Microbiota 2022. [DOI: 10.1016/b978-0-12-819265-8.00094-2] [Reference Citation Analysis]
|
| 60 |
Iribarren C, Maasfeh L, Öhman L, Simrén M. Modulating the gut microenvironment as a treatment strategy for irritable bowel syndrome: a narrative review. Gut Microb 2022;3:e7. [DOI: 10.1017/gmb.2022.6] [Reference Citation Analysis]
|
| 61 |
Hitch TCA, Hall LJ, Walsh SK, Leventhal GE, Slack E, de Wouters T, Walter J, Clavel T. Microbiome-based interventions to modulate gut ecology and the immune system. Mucosal Immunol 2022;15:1095-113. [PMID: 36180583 DOI: 10.1038/s41385-022-00564-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 62 |
Ali SA, Panda SR, Dey M, Datusalia AK, Naidu VGM, Singh RK. The Factors Influencing Gut Microbiota in Autoimmune Diseases. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-1946-6_4] [Reference Citation Analysis]
|
| 63 |
Chen S, Luo S, Yan C. Gut Microbiota Implications for Health and Welfare in Farm Animals: A Review. Animals (Basel) 2021;12:93. [PMID: 35011199 DOI: 10.3390/ani12010093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 64 |
Yang YP, Zhang XY, Cui BT, Zhang H, Wu ZF, Tan X, Cheng W, Zhu X, Zhang FM, Qin HL, Wei H. Preclinical safety, effectiveness evaluation, and screening of functional bacteria for fecal microbiota transplantation based on germ-free animals. World J Meta-Anal 2021; 9(6): 496-504 [DOI: 10.13105/wjma.v9.i6.496] [Reference Citation Analysis]
|
| 65 |
Turjeman S, Koren O. Using the microbiome in clinical practice. Microb Biotechnol 2022;15:129-34. [PMID: 34767683 DOI: 10.1111/1751-7915.13971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 66 |
Chen CC, Chiu CH. Current and future applications of fecal microbiota transplantation for children. Biomed J 2021:S2319-4170(21)00153-0. [PMID: 34781002 DOI: 10.1016/j.bj.2021.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 67 |
Ma S, Wang N, Zhang P, Wu W, Fu L. Fecal microbiota transplantation mitigates bone loss by improving gut microbiome composition and gut barrier function in aged rats. PeerJ 2021;9:e12293. [PMID: 34721980 DOI: 10.7717/peerj.12293] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 68 |
Gu X, Lu Q, Zhang C, Tang Z, Chu L. Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review. Semin Liver Dis 2021;41:495-506. [PMID: 34261137 DOI: 10.1055/s-0041-1732319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 69 |
Dubost JM, Kongchack P, Deharo E, Sysay P, Her C, Vichith L, Sébastien D, Krief S. Zootherapeutic uses of animals excreta: the case of elephant dung and urine use in Sayaboury province, Laos. J Ethnobiol Ethnomed 2021;17:62. [PMID: 34711254 DOI: 10.1186/s13002-021-00484-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Yan C, Xiao J, Li Z, Liu H, Zhao X, Liu J, Chen S, Zhao X. Exogenous Fecal Microbial Transplantation Alters Fearfulness, Intestinal Morphology, and Gut Microbiota in Broilers. Front Vet Sci 2021;8:706987. [PMID: 34660756 DOI: 10.3389/fvets.2021.706987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 71 |
Zhang L, Zhan H, Xu W, Yan S, Ng SC. The role of gut mycobiome in health and diseases. Therap Adv Gastroenterol 2021;14:17562848211047130. [PMID: 34589139 DOI: 10.1177/17562848211047130] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 72 |
Ashraf MF, Tageldin O, Nassar Y, Batool A. Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection: A Four-Year Single-Center Retrospective Review. Gastroenterology Res 2021;14:237-43. [PMID: 34527093 DOI: 10.14740/gr1436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Houf J. Faecal microbiota transplants: towards a healthy disgust scepticism. Med Humanit 2021;47:407-16. [PMID: 34509994 DOI: 10.1136/medhum-2020-012135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 74 |
Kang YB, Cai Y. Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer. World J Gastroenterol 2021;27:5362-75. [PMID: 34539138 DOI: 10.3748/wjg.v27.i32.5362] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 75 |
Nandwana V, Debbarma S. Fecal Microbiota Transplantation: A Microbiome Modulation Technique for Alzheimer's Disease. Cureus 2021;13:e16503. [PMID: 34430117 DOI: 10.7759/cureus.16503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 76 |
Shao HQ, Tan ZJ. Microbiota-targeted therapeutics in gastrointestinal diseases. Shijie Huaren Xiaohua Zazhi 2021; 29(15): 841-848 [DOI: 10.11569/wcjd.v29.i15.841] [Reference Citation Analysis]
|
| 77 |
Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
|
| 78 |
Bonanomi G, Idbella M, Abd-elgawad AM. Microbiota Management for Effective Disease Suppression: A Systematic Comparison between Soil and Mammals Gut. Sustainability 2021;13:7608. [DOI: 10.3390/su13147608] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 79 |
Houf JR. Boundary Work and Boundary Objects: Synthesizing Two Concepts for Moments of Controversy. Journal of Technical Writing and Communication 2021;51:293-312. [DOI: 10.1177/0047281620947355] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 80 |
Gupta M, Krishan P, Kaur A, Arora S, Trehanpati N, Singh TG, Bedi O. Mechanistic and physiological approaches of fecal microbiota transplantation in the management of NAFLD. Inflamm Res 2021;70:765-76. [PMID: 34212214 DOI: 10.1007/s00011-021-01480-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 81 |
Wang B, Wang L, Wang H, Dai H, Lu X, Lee YK, Gu Z, Zhao J, Zhang H, Chen W, Wang G. Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders. J Nutr 2021;151:1703-16. [PMID: 33982127 DOI: 10.1093/jn/nxab103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 82 |
El-Salhy M, Patcharatrakul T, Gonlachanvit S. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century. World J Gastroenterol 2021; 27(22): 2921-2943 [PMID: 34168399 DOI: 10.3748/wjg.v27.i22.2921] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 83 |
Yeh YM, Cheng HT, Le PH, Chen CC, Kuo CJ, Chen CL, Chiu CT, Chiu CH. Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome. Biomed J 2021:S2319-4170(21)00067-6. [PMID: 34118466 DOI: 10.1016/j.bj.2021.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 84 |
Hanssen NMJ, de Vos WM, Nieuwdorp M. Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? Cell Metab 2021;33:1098-110. [PMID: 34077717 DOI: 10.1016/j.cmet.2021.05.005] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 85 |
Ser HL, Letchumanan V, Goh BH, Wong SH, Lee LH. The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop? Front Microbiol 2021;12:519836. [PMID: 34054740 DOI: 10.3389/fmicb.2021.519836] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 86 |
Zhu R, Lang T, Yan W, Zhu X, Huang X, Yin Q, Li Y. Gut Microbiota: Influence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Adv Sci (Weinh) 2021;8:2003542. [PMID: 34026439 DOI: 10.1002/advs.202003542] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 87 |
Tadashi O. Current status, complications and prospects of fecal microbiota transplantation therapy. Arch Pathol Clin Res 2021;5:004-009. [DOI: 10.29328/journal.apcr.1001021] [Reference Citation Analysis]
|
| 88 |
Schmidt EKA, Raposo PJF, Madsen KL, Fenrich KK, Kabarchuk G, Fouad K. What Makes a Successful Donor? Fecal Transplant from Anxious-Like Rats Does Not Prevent Spinal Cord Injury-Induced Dysbiosis. Biology (Basel) 2021;10:254. [PMID: 33804928 DOI: 10.3390/biology10040254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 89 |
Ranallo RT, McDonald LC, Halpin AL, Hiltke T, Young VB. The State of Microbiome Science at the Intersection of Infectious Diseases and Antimicrobial Resistance. J Infect Dis 2021;223:S187-93. [PMID: 33667294 DOI: 10.1093/infdis/jiab020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 90 |
Al-Bakri AG, Akour AA, Al-Delaimy WK. Knowledge, attitudes, ethical and social perspectives towards fecal microbiota transplantation (FMT) among Jordanian healthcare providers. BMC Med Ethics 2021;22:19. [PMID: 33639935 DOI: 10.1186/s12910-021-00587-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 91 |
D Goldenberg S, Merrick B. The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection. Ther Adv Infect Dis 2021;8:2049936120981526. [PMID: 33614028 DOI: 10.1177/2049936120981526] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 92 |
Lee LH, Wong SH, Chin SF, Singh V, Ab Mutalib NS. Editorial: Human Microbiome: Symbiosis to Pathogenesis. Front Microbiol 2021;12:605783. [PMID: 33679632 DOI: 10.3389/fmicb.2021.605783] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 93 |
Ramai D, Zakhia K, Fields PJ, Ofosu A, Patel G, Shahnazarian V, Lai JK, Dhaliwal A, Reddy M, Chang S. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis. Dig Dis Sci 2021;66:369-80. [PMID: 32166622 DOI: 10.1007/s10620-020-06185-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 94 |
Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, Nina PB, Jp D, Kumar S, Singh B, Tiwari RR. Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review. Front Microbiol 2021;12:609459. [PMID: 33574807 DOI: 10.3389/fmicb.2021.609459] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 95 |
Fang H, Fu L, Li X, Lu C, Su Y, Xiong K, Zhang L. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study. Microb Cell Fact 2021;20:18. [PMID: 33468164 DOI: 10.1186/s12934-021-01513-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 96 |
Chen T, Xia C, Hu H, Wang H, Tan B, Tian P, Zhao X, Wang L, Han Y, Deng KY, Wei H, Xin HB. Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination. Int J Antimicrob Agents 2021;57:106277. [PMID: 33434677 DOI: 10.1016/j.ijantimicag.2021.106277] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 97 |
Sommermeyer H, Piątek J. Treatment of CDI. Clostridioides difficile 2021. [DOI: 10.1007/978-3-030-81100-6_8] [Reference Citation Analysis]
|
| 98 |
Schuster IP, Klyachman L, Rajapakse R, Monzur F. New Developments in the Management of Crohn’s Disease. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-81780-0_4] [Reference Citation Analysis]
|
| 99 |
Puricelli C, Rolla R, Gigliotti L, Boggio E, Beltrami E, Dianzani U, Keller R. The Gut-Brain-Immune Axis in Autism Spectrum Disorders: A State-of-Art Report. Front Psychiatry 2021;12:755171. [PMID: 35185631 DOI: 10.3389/fpsyt.2021.755171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 100 |
Davidovics Z. Fecal Transplant. Pediatric Gastrointestinal and Liver Disease 2021. [DOI: 10.1016/b978-0-323-67293-1.00093-1] [Reference Citation Analysis]
|
| 101 |
Joishy TK, Das S, Khan MR. Understanding of Gut Microbial Ecology for New Therapeutics. Microbes in Microbial Communities 2021. [DOI: 10.1007/978-981-16-5617-0_13] [Reference Citation Analysis]
|
| 102 |
Rosenberg E. Microbiomes in Medicine and Agriculture. Microbiomes 2021. [DOI: 10.1007/978-3-030-65317-0_10] [Reference Citation Analysis]
|
| 103 |
Kang Y, Kang X, Zhang H, Liu Q, Yang H, Fan W. Gut Microbiota and Parkinson's Disease: Implications for Faecal Microbiota Transplantation Therapy. ASN Neuro 2021;13:17590914211016217. [PMID: 34053243 DOI: 10.1177/17590914211016217] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 104 |
Knežević D, Petković M. Faecal transplantation and Clostridioides difficile infection. Scripta Medica 2021;52:215-23. [DOI: 10.5937/scriptamed52-32752] [Reference Citation Analysis]
|
| 105 |
Nejadghaderi SA, Nazemalhosseini-Mojarad E, Asadzadeh Aghdaei H. Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy. Med Hypotheses 2021;147:110476. [PMID: 33482620 DOI: 10.1016/j.mehy.2020.110476] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 106 |
Gerardin Y, Timberlake S, Allegretti JR, Smith MB, Kassam Z. Beyond Fecal Microbiota Transplantation: Developing Drugs from the Microbiome. J Infect Dis 2021;223:S276-82. [PMID: 33330910 DOI: 10.1093/infdis/jiaa700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 107 |
Selber-Hnatiw S, Sultana T, Tse W, Abdollahi N, Abdullah S, Al Rahbani J, Alazar D, Alrumhein NJ, Aprikian S, Arshad R, Azuelos JD, Bernadotte D, Beswick N, Chazbey H, Church K, Ciubotaru E, D'Amato L, Del Corpo T, Deng J, Di Giulio BL, Diveeva D, Elahie E, Frank JGM, Furze E, Garner R, Gibbs V, Goldberg-Hall R, Goldman CJ, Goltsios FF, Gorjipour K, Grant T, Greco B, Guliyev N, Habrich A, Hyland H, Ibrahim N, Iozzo T, Jawaheer-Fenaoui A, Jaworski JJ, Jhajj MK, Jones J, Joyette R, Kaudeer S, Kelley S, Kiani S, Koayes M, Kpata AJAL, Maingot S, Martin S, Mathers K, McCullogh S, McNamara K, Mendonca J, Mohammad K, Momtaz SA, Navaratnarajah T, Nguyen-Duong K, Omran M, Ortiz A, Patel A, Paul-Cole K, Plaisir PA, Porras Marroquin JA, Prevost A, Quach A, Rafal AJ, Ramsarun R, Rhnima S, Rili L, Safir N, Samson E, Sandiford RR, Secondi S, Shahid S, Shahroozi M, Sidibé F, Smith M, Sreng Flores AM, Suarez Ybarra A, Sénéchal R, Taifour T, Tang L, Trapid A, Tremblay Potvin M, Wainberg J, Wang DN, Weissenberg M, White A, Wilkinson G, Williams B, Wilson JR, Zoppi J, Zouboulakis K, Gamberi C. Metabolic networks of the human gut microbiota.Microbiology (Reading). 2020;166:96-119. [PMID: 31799915 DOI: 10.1099/mic.0.000853] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 108 |
Guo W, Ren K, Ning R, Li C, Zhang H, Li D, Xu L, Sun F, Dai M. Fecal microbiota transplantation provides new insight into wildlife conservation. Global Ecology and Conservation 2020;24:e01234. [DOI: 10.1016/j.gecco.2020.e01234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 109 |
Keskey R, Cone JT, DeFazio JR, Alverdy JC. The use of fecal microbiota transplant in sepsis. Transl Res 2020;226:12-25. [PMID: 32649987 DOI: 10.1016/j.trsl.2020.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 110 |
Ding X, Yang X, Wang H. Methodology, efficacy and safety of fecal microbiota transplantation in treating inflammatory bowel disease. Medicine in Microecology 2020;6:100028. [DOI: 10.1016/j.medmic.2020.100028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 111 |
Wargo JA. Modulating gut microbes. Science 2020;369:1302-3. [PMID: 32913089 DOI: 10.1126/science.abc3965] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 112 |
Zommiti M, Feuilloley MGJ, Connil N. Update of Probiotics in Human World: A Nonstop Source of Benefactions till the End of Time. Microorganisms 2020;8:E1907. [PMID: 33266303 DOI: 10.3390/microorganisms8121907] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 113 |
Sas EI, Grinevich VB, Barnakova VA. Fecal transplantation: clinical realities and prospects in the treatment of metabolic syndrome. jour 2020;183:102-112. [DOI: 10.31146/1682-8658-ecg-183-11-102-112] [Reference Citation Analysis]
|
| 114 |
Napolitano M, Covasa M. Microbiota Transplant in the Treatment of Obesity and Diabetes: Current and Future Perspectives. Front Microbiol 2020;11:590370. [PMID: 33304339 DOI: 10.3389/fmicb.2020.590370] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 115 |
Khan Mirzaei M, Deng L. Sustainable Microbiome: a symphony orchestrated by synthetic phages. Microb Biotechnol 2021;14:45-50. [PMID: 33171009 DOI: 10.1111/1751-7915.13697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 116 |
Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 117 |
Grigoryan Z, Shen MJ, Twardus SW, Beuttler MM, Chen LA, Bateman-House A. Fecal microbiota transplantation: Uses, questions, and ethics. Med Microecol 2020;6:100027. [PMID: 33834162 DOI: 10.1016/j.medmic.2020.100027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 118 |
Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes. Front Immunol 2020;11:571731. [PMID: 33178196 DOI: 10.3389/fimmu.2020.571731] [Cited by in Crossref: 91] [Cited by in F6Publishing: 99] [Article Influence: 30.3] [Reference Citation Analysis]
|
| 119 |
Kumar SB, Arnipalli SR, Ziouzenkova O. Antibiotics in Food Chain: The Consequences for Antibiotic Resistance. Antibiotics (Basel) 2020;9:E688. [PMID: 33066005 DOI: 10.3390/antibiotics9100688] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 120 |
Sharma AP, Burton J, Filler G, Dave S. Current update and future directions on gut microbiome and nephrolithiasis. Indian J Urol 2020;36:262-9. [PMID: 33376261 DOI: 10.4103/iju.IJU_20_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 121 |
Li Q, Guo L, Wang L, Miao J, Cui H, Li L, Geng K, Zhao L, Sun X, Jia J, Bian Y. Composition of "gold juice" using an ancient method based on intestinal microecology. J Int Med Res 2020;48:300060520931288. [PMID: 32993381 DOI: 10.1177/0300060520931288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 122 |
Terra DAA, Vilela EG, Silva ROS, LeÃo LA, Lima KS, Passos RIFÂ, Diniz AN, Coelho LGV. STRUCTURING A FECAL MICROBIOTA TRANSPLANTATION CENTER IN A UNIVERSITY HOSPITAL IN BRAZIL. Arq Gastroenterol 2020;57:434-58. [PMID: 33331486 DOI: 10.1590/S0004-2803.202000000-79] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 123 |
Zhong M, Sun Y, Wang HG, Marcella C, Cui BT, Miao YL, Zhang FM. Awareness and attitude of fecal microbiota transplantation through transendoscopic enteral tubing among inflammatory bowel disease patients. World J Clin Cases 2020; 8(17): 3786-3796 [PMID: 32953854 DOI: 10.12998/wjcc.v8.i17.3786] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 124 |
Raghu Subramanian C, Talluri S, Khan SU, Katz JA, Georgetson M, Sinh P. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Multiple Comorbidities: Long-Term Safety and Efficacy Results From a Tertiary Care Community Hospital. Gastroenterology Res 2020;13:138-45. [PMID: 32864024 DOI: 10.14740/gr1275] [Reference Citation Analysis]
|
| 125 |
Li K, Wei S, Hu L, Yin X, Mai Y, Jiang C, Peng X, Cao X, Huang Z, Zhou H, Ma G, Liu Z, Li H, Zhao B. Protection of Fecal Microbiota Transplantation in a Mouse Model of Multiple Sclerosis. Mediators Inflamm 2020;2020:2058272. [PMID: 32831634 DOI: 10.1155/2020/2058272] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 126 |
Ianiro G, Segal JP, Mullish BH, Quraishi MN, Porcari S, Fabiani G, Gasbarrini A, Cammarota G. Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders. Future Microbiol 2020;15:1173-83. [PMID: 32954843 DOI: 10.2217/fmb-2020-0061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 127 |
Fitzgerald MJ, Spek EJ. Microbiome therapeutics and patent protection. Nat Biotechnol 2020;38:806-10. [DOI: 10.1038/s41587-020-0579-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 128 |
Shasthry SM. Fecal microbiota transplantation in alcohol related liver diseases. Clin Mol Hepatol 2020;26:294-301. [PMID: 32570299 DOI: 10.3350/cmh.2020.0057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 129 |
Wang Y, Ren R, Sun G, Peng L, Tian Y, Yang Y. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. Int Immunopharmacol 2020;85:106661. [PMID: 32563025 DOI: 10.1016/j.intimp.2020.106661] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 130 |
Chinna Meyyappan A, Forth E, Wallace CJK, Milev R. Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review. BMC Psychiatry 2020;20:299. [PMID: 32539741 DOI: 10.1186/s12888-020-02654-5] [Cited by in Crossref: 81] [Cited by in F6Publishing: 82] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 131 |
Zhang C, Huang J, Ren Y, Zhu S, Yin F, Zhu Y. The Influence and Treatment of the Intestinal Microbiome on Child Respiratory Diseases. Infectious Microbes and Diseases 2020;2:107-114. [DOI: 10.1097/im9.0000000000000028] [Reference Citation Analysis]
|
| 132 |
Soo WT, Bryant RV, Costello SP. Faecal microbiota transplantation: indications, evidence and safety. Aust Prescr 2020;43:36-8. [PMID: 32346208 DOI: 10.18773/austprescr.2020.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 133 |
Honggang W, Xiaozhong Y. China’s contribution to gut microbiota research. Arch Community Med Public Health 2020;6:049-052. [DOI: 10.17352/2455-5479.000074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 134 |
Teng T, Gao F, He W, Fu H, Guo J, Bai G, Shi B. An Early Fecal Microbiota Transfer Improves the Intestinal Conditions on Microflora and Immunoglobulin and Antimicrobial Peptides in Piglets. J Agric Food Chem 2020;68:4830-43. [PMID: 32252520 DOI: 10.1021/acs.jafc.0c00545] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 135 |
Nicco C, Paule A, Konturek P, Edeas M. From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation. Diseases 2020;8:E9. [PMID: 32326509 DOI: 10.3390/diseases8020009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 136 |
Fang H, Fu L, Li X, Wang J, Xiong K, Su Y, Zhang L. Long-term efficacy and safety of single fecal microbiota transplantation for recurrent active ulcerative colitis.. [DOI: 10.1101/2020.03.16.20022293] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 137 |
Hamilton LA, Behal ML. Altering Routine Intensive Care Unit Practices to Support Commensalism. Nutr Clin Pract 2020;35:433-41. [PMID: 32189422 DOI: 10.1002/ncp.10484] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 138 |
Gupta A, Saha S, Khanna S. Therapies to modulate gut microbiota: Past, present and future. World J Gastroenterol 2020; 26(8): 777-788 [PMID: 32148376 DOI: 10.3748/wjg.v26.i8.777] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 139 |
Cheng YW, Fischer M. Fecal Microbiota Transplantation: Redefining Surgical Management of Refractory Clostridium difficile Infection. Clin Colon Rectal Surg 2020;33:92-7. [PMID: 32104162 DOI: 10.1055/s-0040-1701233] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 140 |
Ding X, Li Q, Li P, Zhang T, Cui B, Ji G, Lu X, Zhang F. Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis. Drug Saf. 2019;42:869-880. [PMID: 30972640 DOI: 10.1007/s40264-019-00809-2] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 141 |
Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, Chen Y, Yin H, Wang H, Marcella C, Cui B, Cheng L, Ji G, Zhang F. Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell. 2020;11:251-266. [PMID: 31919742 DOI: 10.1007/s13238-019-00684-8] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 26.3] [Reference Citation Analysis]
|
| 142 |
Zhu X, Hu J, Deng S, Tan Y, Qiu C, Zhang M, Ni X, Lu H, Wang Z, Li L, Chen H, Huang S, Xiao T, Shang D, Wen Y. Bibliometric and Visual Analysis of Research on the Links Between the Gut Microbiota and Depression From 1999 to 2019. Front Psychiatry 2020;11:587670. [PMID: 33488420 DOI: 10.3389/fpsyt.2020.587670] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 143 |
Chowdhury G, Ramamurthy T. Influence of Antimicrobials on the Gut Microbiota. Antimicrobial Resistance 2020. [DOI: 10.1007/978-981-15-3658-8_3] [Reference Citation Analysis]
|
| 144 |
Kraeuter AK, Phillips R, Sarnyai Z. The Gut Microbiome in Psychosis From Mice to Men: A Systematic Review of Preclinical and Clinical Studies. Front Psychiatry 2020;11:799. [PMID: 32903683 DOI: 10.3389/fpsyt.2020.00799] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 145 |
Heimesaat MM, Mrazek K, Bereswill S. Murine fecal microbiota transplantation lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses in Campylobacter jejuni infected secondary abiotic mice. Sci Rep 2019;9:19797. [PMID: 31875037 DOI: 10.1038/s41598-019-56442-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 146 |
Ebrahimzadeh Leylabadlo H, Ghotaslou R, Samadi Kafil H, Feizabadi MM, Moaddab SY, Farajnia S, Sheykhsaran E, Sanaie S, Shanehbandi D, Bannazadeh Baghi H. Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. Eur J Clin Microbiol Infect Dis 2020;39:613-27. [PMID: 31828683 DOI: 10.1007/s10096-019-03746-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 147 |
Leung PC, Cheng KF. Fecal microbiota transplantation: Historical review and current perspective. World J Meta-Anal 2019; 7(9): 423-427 [DOI: 10.13105/wjma.v7.i9.423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 148 |
He Y, Li X, Yu H, Ge Y, Liu Y, Qin X, Jiang M, Wang X. The Functional Role of Fecal Microbiota Transplantation on Dextran Sulfate Sodium-Induced Colitis in Mice. Front Cell Infect Microbiol 2019;9:393. [PMID: 31803633 DOI: 10.3389/fcimb.2019.00393] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 149 |
Yang D, Zhao D, Ali Shah SZ, Wu W, Lai M, Zhang X, Li J, Guan Z, Zhao H, Li W, Gao H, Zhou X, Yang L. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Front Neurol 2019;10:1155. [PMID: 31781020 DOI: 10.3389/fneur.2019.01155] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 150 |
Madar PC, Petre O, Baban A, Dumitrascu DL. Medical students' perception on fecal microbiota transplantation. BMC Med Educ 2019;19:368. [PMID: 31601212 DOI: 10.1186/s12909-019-1804-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 151 |
Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, Câmara NOS. Inflammation in Renal Diseases: New and Old Players. Front Pharmacol 2019;10:1192. [PMID: 31649546 DOI: 10.3389/fphar.2019.01192] [Cited by in Crossref: 123] [Cited by in F6Publishing: 130] [Article Influence: 30.8] [Reference Citation Analysis]
|
| 152 |
Cryan JF, O'riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-smith CM, Lyte JM, Martin JA, Molinero-perez A, Moloney G, Morelli E, Morillas E, O'connor R, Cruz-pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-silva AP, Wallace-fitzsimons SE, Hyland N, Clarke G, Dinan TG. The Microbiota-Gut-Brain Axis. Physiological Reviews 2019;99:1877-2013. [DOI: 10.1152/physrev.00018.2018] [Cited by in Crossref: 1156] [Cited by in F6Publishing: 1243] [Article Influence: 289.0] [Reference Citation Analysis]
|
| 153 |
Jayachandran M, Chung SSM, Xu B. A critical review on diet-induced microbiota changes and cardiovascular diseases. Crit Rev Food Sci Nutr 2020;60:2914-25. [PMID: 31552753 DOI: 10.1080/10408398.2019.1666792] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 154 |
Heimesaat MM, Mrazek K, Bereswill S. Murine Fecal Microbiota Transplantation Alleviates Intestinal and Systemic Immune Responses in Campylobacter jejuni Infected Mice Harboring a Human Gut Microbiota. Front Immunol 2019;10:2272. [PMID: 31616437 DOI: 10.3389/fimmu.2019.02272] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 155 |
Mandrioli J, Amedei A, Cammarota G, Niccolai E, Zucchi E, D'Amico R, Ricci F, Quaranta G, Spanu T, Masucci L. FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis. Front Neurol 2019;10:1021. [PMID: 31620079 DOI: 10.3389/fneur.2019.01021] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 156 |
Du H, Kuang TT, Qiu S, Xu T, Gang Huan CL, Fan G, Zhang Y. Fecal medicines used in traditional medical system of China: a systematic review of their names, original species, traditional uses, and modern investigations. Chin Med 2019;14:31. [PMID: 31528199 DOI: 10.1186/s13020-019-0253-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 157 |
Wu X, Dai M, Buch H, Bai J, Long W, Long C, Tang X, Tu H, Zhang R, Zhu C, Yang S, Cui B, Ji G, Zhang F. The recognition and attitudes of postgraduate medical students toward fecal microbiota transplantation: a questionnaire study. Therap Adv Gastroenterol 2019;12:1756284819869144. [PMID: 31516555 DOI: 10.1177/1756284819869144] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 158 |
D'Haens GR, Jobin C. Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection. Gastroenterology 2019;157:624-36. [PMID: 31220424 DOI: 10.1053/j.gastro.2019.04.053] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
|
| 159 |
Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 58] [Cited by in F6Publishing: 65] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 160 |
Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 2019;7:e7502. [PMID: 31440436 DOI: 10.7717/peerj.7502] [Cited by in Crossref: 187] [Cited by in F6Publishing: 200] [Article Influence: 46.8] [Reference Citation Analysis]
|
| 161 |
Parker A, Fonseca S, Carding SR. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes 2020;11:135-57. [PMID: 31368397 DOI: 10.1080/19490976.2019.1638722] [Cited by in Crossref: 193] [Cited by in F6Publishing: 185] [Article Influence: 48.3] [Reference Citation Analysis]
|
| 162 |
Kenyon J, Coe S, Izadi H. A retrospective outcome study of 42 patients with Chronic Fatigue Syndrome, 30 of whom had Irritable Bowel Syndrome. Half were treated with oral approaches, and half were treated with Faecal Microbiome Transplantation. Human Microbiome Journal 2019;13:100061. [DOI: 10.1016/j.humic.2019.100061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 163 |
Murphy CL, Zulquernain SA, Shanahan F. Faecal Microbiota Transplantation (FMT) - classical bedside-to-bench clinical research. QJM 2019:hcz181. [PMID: 31297516 DOI: 10.1093/qjmed/hcz181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 164 |
Canibe N, O'Dea M, Abraham S. Potential relevance of pig gut content transplantation for production and research. J Anim Sci Biotechnol 2019;10:55. [PMID: 31304012 DOI: 10.1186/s40104-019-0363-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 165 |
Jørgensen SMD, Hvas CL, Dahlerup JF, Mikkelsen S, Ehlers L, Hammeken LH, Licht TR, Bahl MI, Erikstrup C. Banking feces: a new frontier for public blood banks? Transfusion 2019;59:2776-82. [PMID: 31241182 DOI: 10.1111/trf.15422] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 166 |
Woodworth MH, Hayden MK, Young VB, Kwon JH. The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions. Open Forum Infect Dis 2019;6:ofz288. [PMID: 31363779 DOI: 10.1093/ofid/ofz288] [Cited by in Crossref: 15] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 167 |
Wortelboer K, Nieuwdorp M, Herrema H. Fecal microbiota transplantation beyond Clostridioides difficile infections. EBioMedicine 2019;44:716-29. [PMID: 31201141 DOI: 10.1016/j.ebiom.2019.05.066] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 168 |
Srikumar S, Fanning S. The Therapeutic Potential of the “Yin-Yang” Garden in Our Gut. Role of Microbes in Human Health and Diseases 2019. [DOI: 10.5772/intechopen.80881] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 169 |
Wu X, Zhang T, Chen X, Ji G, Zhang F. Microbiota transplantation: Targeting cancer treatment. Cancer Letters 2019;452:144-51. [DOI: 10.1016/j.canlet.2019.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 170 |
Kellermayer R. Fecal microbiota transplantation: great potential with many challenges. Transl Gastroenterol Hepatol 2019;4:40. [PMID: 31231707 DOI: 10.21037/tgh.2019.05.10] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 171 |
Lin C, Wan J, Lu Y, Zhang H, Chen X, Su Y, Zhu W. Active bacterial communities of pig fecal microbiota transplantation suspension prepared and preserved under different conditions. AMB Express 2019;9:63. [PMID: 31076926 DOI: 10.1186/s13568-019-0787-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 172 |
Zhang F, Zhang T, Zhu H, Borody TJ. Evolution of fecal microbiota transplantation in methodology and ethical issues. CurrOpinPharmacol. 2019;49:11-16. [PMID: 31059962 DOI: 10.1016/j.coph.2019.04.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 173 |
Khanna S, Gerding DN. Current and future trends in clostridioides (clostridium) difficile infection management. Anaerobe 2019;58:95-102. [PMID: 31054313 DOI: 10.1016/j.anaerobe.2019.04.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 174 |
Zeng W, Shen J, Bo T, Peng L, Xu H, Nasser MI, Zhuang Q, Zhao M. Cutting Edge: Probiotics and Fecal Microbiota Transplantation in Immunomodulation. J Immunol Res 2019;2019:1603758. [PMID: 31143780 DOI: 10.1155/2019/1603758] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 175 |
Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, Goldman S, Wultańska D, Garlicki A, Biesiada G. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis 2019;38:1211-21. [PMID: 30945014 DOI: 10.1007/s10096-019-03539-6] [Cited by in Crossref: 184] [Cited by in F6Publishing: 154] [Article Influence: 46.0] [Reference Citation Analysis]
|
| 176 |
Falony G, Vandeputte D, Caenepeel C, Vieira-Silva S, Daryoush T, Vermeire S, Raes J. The human microbiome in health and disease: hype or hope. Acta Clin Belg 2019;74:53-64. [PMID: 30810508 DOI: 10.1080/17843286.2019.1583782] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 177 |
Mrazek K, Bereswill S, Heimesaat MM. Fecal Microbiota Transplantation Decreases Intestinal Loads of Multi-Drug Resistant Pseudomonas aeruginosa in Murine Carriers. Eur J Microbiol Immunol (Bp) 2019;9:14-22. [PMID: 30967971 DOI: 10.1556/1886.2019.00002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 178 |
Suk KT, Kim DJ. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 2019;13:193-204. [PMID: 30791767 DOI: 10.1080/17474124.2019.1569513] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 179 |
Wang J, Kuo C, Kuo F, Wang Y, Hsu W, Yu F, Hu H, Hsu P, Wang J, Wu D. Fecal microbiota transplantation: Review and update. Journal of the Formosan Medical Association 2019;118:S23-31. [DOI: 10.1016/j.jfma.2018.08.011] [Cited by in Crossref: 120] [Cited by in F6Publishing: 133] [Article Influence: 30.0] [Reference Citation Analysis]
|
| 180 |
Abu-sbeih H, Ali FS, Wang Y. Clinical Review on the Utility of Fecal Microbiota Transplantation in Immunocompromised Patients. Curr Gastroenterol Rep 2019;21:8. [DOI: 10.1007/s11894-019-0677-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 181 |
Li Y, Zou Z, Bian X, Huang Y, Wang Y, Yang C, Zhao J, Xie L. Fecal microbiota transplantation research output from 2004 to 2017: a bibliometric analysis. PeerJ. 2019;7:e6411. [PMID: 30809438 DOI: 10.7717/peerj.6411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 182 |
Jin Song S, Woodhams DC, Martino C, Allaband C, Mu A, Javorschi-Miller-Montgomery S, Suchodolski JS, Knight R. Engineering the microbiome for animal health and conservation. Exp Biol Med (Maywood) 2019;244:494-504. [PMID: 30776908 DOI: 10.1177/1535370219830075] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 183 |
Wang P, Li D, Ke W, Liang D, Hu X, Chen F. Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice. Int J Obes (Lond) 2020;44:213-25. [PMID: 30718820 DOI: 10.1038/s41366-019-0332-1] [Cited by in Crossref: 118] [Cited by in F6Publishing: 123] [Article Influence: 29.5] [Reference Citation Analysis]
|
| 184 |
Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol 2019;70:260-72. [PMID: 30658727 DOI: 10.1016/j.jhep.2018.10.019] [Cited by in Crossref: 132] [Cited by in F6Publishing: 132] [Article Influence: 33.0] [Reference Citation Analysis]
|
| 185 |
Yang Y, Ai G, Wang M. Alcoholic liver disease and intestinal microecology. Shijie Huaren Xiaohua Zazhi 2019; 27(1): 43-49 [DOI: 10.11569/wcjd.v27.i1.43] [Reference Citation Analysis]
|
| 186 |
Evrensel A, Ceylan ME. Fecal Microbiota Transplantation in the Treatment-Resistant Psychiatric Disorders. Treatment Resistance in Psychiatry 2019. [DOI: 10.1007/978-981-10-4358-1_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 187 |
Zucko J, Starcevic A, Diminic J, Oros D. Microbiota: Novel Gateway Towards Personalised Medicine. Personalized Medicine in Healthcare Systems 2019. [DOI: 10.1007/978-3-030-16465-2_9] [Reference Citation Analysis]
|
| 188 |
Borody T. Fecal Microbiota Transplantation. Gastrointestinal Diseases and their Associated Infections 2019. [DOI: 10.1016/b978-0-323-54843-4.00018-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 189 |
Davidovics ZH, Michail S, Nicholson MR, Kociolek LK, Pai N, Hansen R, Schwerd T, Maspons A, Shamir R, Szajewska H, Thapar N, de Meij T, Mosca A, Vandenplas Y, Kahn SA, Kellermayer R; FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European Society for Pediatric Gastroenterology Hepatology, Nutrition. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2019;68:130-43. [PMID: 30540704 DOI: 10.1097/MPG.0000000000002205] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 190 |
Ghattargi VC, Sape K, Kumbhare SV, Shouche YS. Mining Human Microbiome for Therapeutics. Microbial Diversity in Ecosystem Sustainability and Biotechnological Applications 2019. [DOI: 10.1007/978-981-13-8315-1_18] [Reference Citation Analysis]
|
| 191 |
Chen D, Wu J, Jin D, Wang B, Cao H. Fecal microbiota transplantation in cancer management: Current status and perspectives. Int J Cancer. 2018;. [PMID: 30458058 DOI: 10.1002/ijc.32003] [Cited by in Crossref: 113] [Cited by in F6Publishing: 123] [Article Influence: 22.6] [Reference Citation Analysis]
|
| 192 |
Moelling K, Broecker F, Willy C. A Wake-Up Call: We Need Phage Therapy Now. Viruses 2018;10:E688. [PMID: 30563034 DOI: 10.3390/v10120688] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 14.8] [Reference Citation Analysis]
|
| 193 |
Moore AM, Mathias M, Valeur J. Contextualising the microbiota-gut-brain axis in history and culture. Microb Ecol Health Dis 2019;30:1546267. [PMID: 30455619 DOI: 10.1080/16512235.2019.1546267] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 194 |
Niederwerder MC. Fecal microbiota transplantation as a tool to treat and reduce susceptibility to disease in animals. Vet Immunol Immunopathol 2018;206:65-72. [PMID: 30502914 DOI: 10.1016/j.vetimm.2018.11.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 195 |
Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci 2019;76:473-93. [DOI: 10.1007/s00018-018-2943-4] [Cited by in Crossref: 211] [Cited by in F6Publishing: 236] [Article Influence: 42.2] [Reference Citation Analysis]
|
| 196 |
Fang H, Fu L, Wang J. Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Biomed Res Int. 2018;2018:8941340. [PMID: 30302341 DOI: 10.1155/2018/8941340] [Cited by in Crossref: 43] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 197 |
Sun MF, Shen YQ. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease. Ageing Res Rev 2018;45:53-61. [PMID: 29705121 DOI: 10.1016/j.arr.2018.04.004] [Cited by in Crossref: 154] [Cited by in F6Publishing: 141] [Article Influence: 30.8] [Reference Citation Analysis]
|
| 198 |
Filip M, Tzaneva V, Dumitrascu DL. Fecal transplantation: digestive and extradigestive clinical applications. Clujul Med 2018;91:259-65. [PMID: 30093802 DOI: 10.15386/cjmed-946] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 199 |
Niederwerder MC, Constance LA, Rowland RRR, Abbas W, Fernando SC, Potter ML, Sheahan MA, Burkey TE, Hesse RA, Cino-Ozuna AG. Fecal Microbiota Transplantation Is Associated With Reduced Morbidity and Mortality in Porcine Circovirus Associated Disease. Front Microbiol 2018;9:1631. [PMID: 30083142 DOI: 10.3389/fmicb.2018.01631] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 200 |
Larroya-García A, Navas-Carrillo D, Orenes-Piñero E. Impact of gut microbiota on neurological diseases: Diet composition and novel treatments. Crit Rev Food Sci Nutr 2019;59:3102-16. [PMID: 29870270 DOI: 10.1080/10408398.2018.1484340] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 201 |
Ribaldone DG, Pellicano R, Actis GC. Inflammation: a highly conserved, Janus-like phenomenon—a gastroenterologist’ perspective. J Mol Med 2018;96:861-71. [DOI: 10.1007/s00109-018-1668-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 202 |
Wang J, Wang P, Tian H, Tian F, Zhang Y, Zhang L, Gao X, Wang X. Aryl hydrocarbon receptor/IL-22/Stat3 signaling pathway is involved in the modulation of intestinal mucosa antimicrobial molecules by commensal microbiota in mice. Innate Immun 2018;24:297-306. [PMID: 29976114 DOI: 10.1177/1753425918785016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 203 |
Hu J, Chen L, Tang Y, Xie C, Xu B, Shi M, Zheng W, Zhou S, Wang X, Liu L, Yan Y, Yang T, Niu Y, Hou Q, Xu X, Yan X. Standardized Preparation for Fecal Microbiota Transplantation in Pigs. Front Microbiol 2018;9:1328. [PMID: 29971061 DOI: 10.3389/fmicb.2018.01328] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 204 |
Baktash A, Terveer EM, Zwittink RD, Hornung BVH, Corver J, Kuijper EJ, Smits WK. Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections. Front Microbiol 2018;9:1242. [PMID: 29946308 DOI: 10.3389/fmicb.2018.01242] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 205 |
Vasquez KS, Shiver AL, Huang KC. Cutting the Gordian Knot of the Microbiota. Mol Cell 2018;70:765-7. [PMID: 29883604 DOI: 10.1016/j.molcel.2018.05.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 206 |
D'Odorico I, Di Bella S, Monticelli J, Giacobbe DR, Boldock E, Luzzati R. Role of fecal microbiota transplantation in inflammatory bowel disease. J Dig Dis 2018;19:322-34. [PMID: 29696802 DOI: 10.1111/1751-2980.12603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 207 |
Volkmann ER. Intestinal microbiome in scleroderma: recent progress. Curr Opin Rheumatol 2017;29:553-60. [PMID: 28719392 DOI: 10.1097/BOR.0000000000000429] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 208 |
Collins J, Auchtung JM. Control of Clostridium difficile Infection by Defined Microbial Communities. Microbiol Spectr 2017;5. [PMID: 28936948 DOI: 10.1128/microbiolspec.BAD-0009-2016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 209 |
Wang HG, Liu SP, Ma TH, Yan W, Zhou JF, Shi YT, Shen P, Yang XZ, Wu SN. Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid: A case report. Medicine (Baltimore) 2018;97:e0675. [PMID: 29742710 DOI: 10.1097/MD.0000000000010675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 210 |
Segal JP, Abbasi F, Kanagasundaram C, Hart A. Does the Internet promote the unregulated use of fecal microbiota transplantation: a potential public health issue? Clin Exp Gastroenterol 2018;11:179-83. [PMID: 29750050 DOI: 10.2147/CEG.S159609] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 211 |
Kang Y, Cai Y. Future prospect of faecal microbiota transplantation as a potential therapy in asthma. Allergol Immunopathol (Madr) 2018;46:307-9. [PMID: 28803667 DOI: 10.1016/j.aller.2017.04.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 212 |
Zhang F, Cui B, He X, Nie Y, Wu K, Fan D; FMT-standardization Study Group. Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell. 2018;9:462-473. [PMID: 29691757 DOI: 10.1007/s13238-018-0541-8] [Cited by in Crossref: 127] [Cited by in F6Publishing: 134] [Article Influence: 25.4] [Reference Citation Analysis]
|
| 213 |
Bakker GJ, Nieuwdorp M. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. Microbiol Spectr 2017;5. [PMID: 28840809 DOI: 10.1128/microbiolspec.BAD-0008-2017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 214 |
Meijnikman AS, Gerdes VE, Nieuwdorp M, Herrema H. Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans. Endocr Rev 2018;39:133-53. [PMID: 29309555 DOI: 10.1210/er.2017-00192] [Cited by in Crossref: 168] [Cited by in F6Publishing: 156] [Article Influence: 33.6] [Reference Citation Analysis]
|
| 215 |
Lübbert C, Salzberger B, Mössner J. [Fecal microbiota transplantation]. Internist (Berl) 2017;58:456-68. [PMID: 28235986 DOI: 10.1007/s00108-017-0203-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 216 |
Jiang Z, Jacob JA, Li J, Wu X, Wei G, Vimalanathan A, Mani R, Nainangu P, Rajadurai UM, Chen B. Influence of diet and dietary nanoparticles on gut dysbiosis. Microb Pathog 2018;118:61-5. [PMID: 29530804 DOI: 10.1016/j.micpath.2018.03.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 217 |
Bruce-Keller AJ, Salbaum JM, Berthoud HR. Harnessing Gut Microbes for Mental Health: Getting From Here to There. Biol Psychiatry 2018;83:214-23. [PMID: 29031410 DOI: 10.1016/j.biopsych.2017.08.014] [Cited by in Crossref: 107] [Cited by in F6Publishing: 109] [Article Influence: 21.4] [Reference Citation Analysis]
|
| 218 |
Chen B, Avinashi V, Dobson S. Fecal microbiota transplantation for recurrent clostridium difficile infection in children. J Infect 2017;74 Suppl 1:S120-7. [PMID: 28646951 DOI: 10.1016/S0163-4453(17)30202-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 219 |
Collins J, Auchtung JM. Control ofClostridium difficileInfection by Defined Microbial Communities. Bugs as Drugs 2018. [DOI: 10.1128/9781555819705.ch11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 220 |
Bakker GJ, Nieuwdorp M. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond Clostridium difficile. Bugs as Drugs 2018. [DOI: 10.1128/9781555819705.ch12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 221 |
Schneider A, Maric L. Fecal Microbiota Transplantation as Therapy for Inflammatory Bowel Disease. Interventional Inflammatory Bowel Disease: Endoscopic Management and Treatment of Complications 2018. [DOI: 10.1016/b978-0-12-811388-2.00028-2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 222 |
Evrensel A, Ceylan ME. Gut-Microbiota-Brain Axis and Depression. Understanding Depression 2018. [DOI: 10.1007/978-981-10-6580-4_17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 223 |
Chis R, Sheth PM, Petrof EO. Fecal Microbiota Transplants: Current Knowledge and Future Directions. Mechanisms Underlying Host-Microbiome Interactions in Pathophysiology of Human Diseases 2018. [DOI: 10.1007/978-1-4939-7534-1_11] [Reference Citation Analysis]
|
| 224 |
Schmidt F, Siegmund B. Fecal Transplantation. The Gut Microbiome in Health and Disease 2018. [DOI: 10.1007/978-3-319-90545-7_20] [Reference Citation Analysis]
|
| 225 |
Tungland B. Dysbiosis of the Microbiota: Therapeutic Strategies Utilizing Dietary Modification, Pro- and Prebiotics and Fecal Transplant Therapies in Promoting Normal Balance and Local GI Functions. Human Microbiota in Health and Disease 2018. [DOI: 10.1016/b978-0-12-814649-1.00009-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 226 |
Battson ML, Lee DM, Weir TL, Gentile CL. The gut microbiota as a novel regulator of cardiovascular function and disease. J Nutr Biochem 2018;56:1-15. [PMID: 29427903 DOI: 10.1016/j.jnutbio.2017.12.010] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 14.7] [Reference Citation Analysis]
|
| 227 |
Ekmekciu I, von Klitzing E, Neumann C, Bacher P, Scheffold A, Bereswill S, Heimesaat MM. Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment. Front Microbiol 2017;8:2430. [PMID: 29321764 DOI: 10.3389/fmicb.2017.02430] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 228 |
Browne AS, Kelly CR. Fecal Transplant in Inflammatory Bowel Disease. Gastroenterol Clin North Am 2017;46:825-37. [PMID: 29173524 DOI: 10.1016/j.gtc.2017.08.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 229 |
Quraishi MN, Critchlow T, Bhala N, Sharma N, Iqbal T. Faecal transplantation for IBD management-pitfalls and promises. Br Med Bull 2017;124:181-90. [PMID: 29140453 DOI: 10.1093/bmb/ldx040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 230 |
Zamudio-tiburcio Á, Bermúdez-ruiz H, Lezama-guzmán HR, Guevara-ortigoza MDP, Islas-solares E, Sosa-lópez FA. Rompiendo paradigmas. Trasplante de microbiota intestinal: reporte preliminar. Cirugía y Cirujanos 2017;85:6-12. [DOI: 10.1016/j.circir.2016.11.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 231 |
Chotirmall SH, Gellatly SL, Budden KF, Mac Aogain M, Shukla SD, Wood DL, Hugenholtz P, Pethe K, Hansbro PM. Microbiomes in respiratory health and disease: An Asia-Pacific perspective. Respirology 2017;22:240-50. [PMID: 28102970 DOI: 10.1111/resp.12971] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 232 |
Khanna S. Microbiota Replacement Therapies: Innovation in Gastrointestinal Care. Clin Pharmacol Ther. 2018;103:102-111. [PMID: 29071710 DOI: 10.1002/cpt.923] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 233 |
Pakpour S, Bhanvadia A, Zhu R, Amarnani A, Gibbons SM, Gurry T, Alm EJ, Martello LA. Identifying predictive features of Clostridium difficile infection recurrence before, during, and after primary antibiotic treatment. Microbiome 2017;5:148. [PMID: 29132405 DOI: 10.1186/s40168-017-0368-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 234 |
Staley C, Khoruts A, Sadowsky MJ. Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans. Archives of Medical Research 2017;48:766-773. [DOI: 10.1016/j.arcmed.2017.11.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 235 |
Khajah MA. The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease. Scand J Gastroenterol 2017;52:1172-84. [PMID: 28685630 DOI: 10.1080/00365521.2017.1347812] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 236 |
Brandt LJ. Fecal Microbiota Therapy With a Focus on Clostridium difficile Infection. Psychosom Med 2017;79:868-73. [PMID: 28976455 DOI: 10.1097/PSY.0000000000000511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 237 |
Moayyedi P, Yuan Y, Baharith H, Ford AC. Faecal microbiota transplantation for Clostridium difficile-associated diarrhoea: a systematic review of randomised controlled trials. Med J Aust. 2017;207:166-172. [PMID: 28814204 DOI: 10.5694/mja17.00295] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 14.2] [Reference Citation Analysis]
|
| 238 |
He Z, Li P, Zhu J, Cui B, Xu L, Xiang J, Zhang T, Long C, Huang G, Ji G, Nie Y, Wu K, Fan D, Zhang F. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn's disease complicated with inflammatory mass. Sci Rep. 2017;7:4753. [PMID: 28684845 DOI: 10.1038/s41598-017-04984-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 8.8] [Reference Citation Analysis]
|
| 239 |
Postler TS, Ghosh S. Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System. Cell Metab 2017;26:110-30. [PMID: 28625867 DOI: 10.1016/j.cmet.2017.05.008] [Cited by in Crossref: 456] [Cited by in F6Publishing: 420] [Article Influence: 76.0] [Reference Citation Analysis]
|
| 240 |
Shin JH, Chaves-Olarte E, Warren CA. Clostridium difficile Infection. Microbiol Spectr 2016;4. [PMID: 27337475 DOI: 10.1128/microbiolspec.EI10-0007-2015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 241 |
Ma Y, Yang J, Cui B, Xu H, Xiao C, Zhang F. How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study. BMC Med Ethics. 2017;18:39. [PMID: 28569156 DOI: 10.1186/s12910-017-0200-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 242 |
He Z, Cui BT, Zhang T, Li P, Long CY, Ji GZ, Zhang FM. Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report. World J Gastroenterol 2017; 23(19): 3565-3568 [PMID: 28596693 DOI: 10.3748/wjg.v23.i19.3565] [Cited by in CrossRef: 130] [Cited by in F6Publishing: 132] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 243 |
Chanyi RM, Craven L, Harvey B, Reid G, Silverman MJ, Burton JP. Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going? SAGE Open Med 2017;5:2050312117708712. [PMID: 28540051 DOI: 10.1177/2050312117708712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 244 |
Lee STM, Kahn SA, Delmont TO, Shaiber A, Esen ÖC, Hubert NA, Morrison HG, Antonopoulos DA, Rubin DT, Eren AM. Tracking microbial colonization in fecal microbiota transplantation experiments via genome-resolved metagenomics. Microbiome 2017;5:50. [PMID: 28473000 DOI: 10.1186/s40168-017-0270-x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 245 |
Cohen NA, Maharshak N. Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature. Dig Dis Sci 2017;62:1131-45. [PMID: 28315032 DOI: 10.1007/s10620-017-4535-9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 246 |
Ma Y, Liu J, Rhodes C, Nie Y, Zhang F. Ethical Issues in Fecal Microbiota Transplantation in Practice. Am J Bioeth 2017;17:34-45. [PMID: 28430065 DOI: 10.1080/15265161.2017.1299240] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 247 |
Li Q, Han Y, Dy ABC, Hagerman RJ. The Gut Microbiota and Autism Spectrum Disorders. Front Cell Neurosci 2017;11:120. [PMID: 28503135 DOI: 10.3389/fncel.2017.00120] [Cited by in Crossref: 236] [Cited by in F6Publishing: 245] [Article Influence: 39.3] [Reference Citation Analysis]
|
| 248 |
Bak SH, Choi HH, Lee J, Kim MH, Lee YH, Kim JS, Cho YS. Fecal microbiota transplantation for refractory Crohn's disease. Intest Res. 2017;15:244-248. [PMID: 28522956 DOI: 10.5217/ir.2017.15.2.244] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 249 |
Fluitman KS, De Clercq NC, Keijser BJ, Visser M, Nieuwdorp M, Ijzerman RG. The intestinal microbiota, energy balance, and malnutrition: emphasis on the role of short-chain fatty acids. Expert Review of Endocrinology & Metabolism 2017;12:215-26. [DOI: 10.1080/17446651.2017.1318060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 250 |
Ekmekciu I, von Klitzing E, Fiebiger U, Escher U, Neumann C, Bacher P, Scheffold A, Kühl AA, Bereswill S, Heimesaat MM. Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice. Front Immunol 2017;8:397. [PMID: 28469619 DOI: 10.3389/fimmu.2017.00397] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 251 |
Liubakka A, Vaughn BP. Clostridium difficile Infection and Fecal Microbiota Transplant. AACN Adv Crit Care. 2016;27:324-337. [PMID: 27959316 DOI: 10.4037/aacnacc2016703] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 252 |
Bachmann R, Leonard D, Delzenne N, Kartheuser A, Cani PD. Novel insight into the role of microbiota in colorectal surgery. Gut 2017;66:738-49. [PMID: 28153961 DOI: 10.1136/gutjnl-2016-312569] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 253 |
Chen DC. Gut Microbiota and Intestinal Decolonization of Pathogenic Microorganisms. Chin Med J (Engl) 2016;129:1639-42. [PMID: 27411449 DOI: 10.4103/0366-6999.185872] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 254 |
Vindigni SM, Surawicz CM. Fecal Microbiota Transplantation. Gastroenterol Clin North Am 2017;46:171-85. [PMID: 28164849 DOI: 10.1016/j.gtc.2016.09.012] [Cited by in Crossref: 126] [Cited by in F6Publishing: 129] [Article Influence: 21.0] [Reference Citation Analysis]
|
| 255 |
de Groot PF, Frissen MN, de Clercq NC, Nieuwdorp M. Fecal microbiota transplantation in metabolic syndrome: History, present and future. Gut Microbes 2017;8:253-67. [PMID: 28609252 DOI: 10.1080/19490976.2017.1293224] [Cited by in Crossref: 166] [Cited by in F6Publishing: 169] [Article Influence: 27.7] [Reference Citation Analysis]
|
| 256 |
Sartor RB, Wu GD. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology 2017;152:327-339.e4. [PMID: 27769810 DOI: 10.1053/j.gastro.2016.10.012] [Cited by in Crossref: 470] [Cited by in F6Publishing: 484] [Article Influence: 78.3] [Reference Citation Analysis]
|
| 257 |
Woodworth MH, Carpentieri C, Sitchenko KL, Kraft CS. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review. Gut Microbes 2017;8:225-37. [PMID: 28129018 DOI: 10.1080/19490976.2017.1286006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 258 |
Evrensel A, Emin Ceylan M. Microbiome: The Missing Link in Neuropsychiatric Disorders. EMJ Innov 2017. [DOI: 10.33590/emjinnov/10313424] [Reference Citation Analysis]
|
| 259 |
Kim WS, Kim HJ. Is Expansion of Fecal Microbiota Transplantation Available? Korean J Gastroenterol 2017;70:211. [DOI: 10.4166/kjg.2017.70.4.211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 260 |
Fine S, Kelly C. FMT in Clostridium difficile and Other Potential Uses. The Microbiota in Gastrointestinal Pathophysiology 2017. [DOI: 10.1016/b978-0-12-804024-9.00034-3] [Reference Citation Analysis]
|
| 261 |
Nikonov EL, Aksenov VA. Transplantation of fecal microbiota or probiotics? Dok gastroenterol 2017;6:19. [DOI: 10.17116/dokgastro20176319-25] [Reference Citation Analysis]
|
| 262 |
Lagier J, Raoult D. Greffe de microbiote fécal et infections: Mise au point, perspectives. Med Sci (Paris) 2016;32:991-7. [DOI: 10.1051/medsci/20163211015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 263 |
Vemuri RC, Gundamaraju R, Shinde T, Eri R. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: Antibiotics, probiotics or faecal microbiota transplantation? Benef Microbes. 2017;8:179-192. [PMID: 28008784 DOI: 10.3920/bm2016.0115] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 264 |
Dodet B. Les enjeux médicaux et sociétaux du microbiote. Med Sci (Paris) 2016;32:1003-8. [DOI: 10.1051/medsci/20163211017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 265 |
Lee ST, Kahn SA, Delmont TO, Hubert NJ, Morrison HG, Antonopoulos DA, Rubin DT, Eren AM. High-resolution tracking of microbial colonization in Fecal Microbiota Transplantation experiments via metagenome-assembled genomes.. [DOI: 10.1101/090993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 266 |
Koopen AM, Groen AK, Nieuwdorp M. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk. Curr Opin Lipidol 2016;27:615-22. [PMID: 27676197 DOI: 10.1097/MOL.0000000000000357] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 267 |
Sharma A, Lal R. Survey of (Meta)genomic Approaches for Understanding Microbial Community Dynamics. Indian J Microbiol 2017;57:23-38. [PMID: 28148977 DOI: 10.1007/s12088-016-0629-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 268 |
Perbal B. To flush or not to flush … that is a question. J Cell Commun Signal 2016;10:337-40. [PMID: 27822878 DOI: 10.1007/s12079-016-0361-7] [Reference Citation Analysis]
|
| 269 |
Tian H, Ding C, Gong J, Ge X, McFarland LV, Gu L, Wei Y, Chen Q, Zhu W, Li J, Li N. Treatment of Slow Transit Constipation With Fecal Microbiota Transplantation: A Pilot Study. J Clin Gastroenterol 2016;50:865-70. [PMID: 26751143 DOI: 10.1097/MCG.0000000000000472] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 270 |
Gianotti RJ, Moss AC. The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2016;22:2704-10. [PMID: 27755271 DOI: 10.1097/MIB.0000000000000950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 271 |
Li D, Wang P, Wang P, Hu X, Chen F. The gut microbiota: A treasure for human health. Biotechnology Advances 2016;34:1210-24. [DOI: 10.1016/j.biotechadv.2016.08.003] [Cited by in Crossref: 115] [Cited by in F6Publishing: 119] [Article Influence: 16.4] [Reference Citation Analysis]
|
| 272 |
Gasbarrini G, Bonvicini F, Gramenzi A. Probiotics History. J Clin Gastroenterol 2016;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S116-9. [PMID: 27741152 DOI: 10.1097/MCG.0000000000000697] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 273 |
Manook A, Hiergeist A, Rupprecht R, Baghai TC. Dickdarmmikrobiom und Depression: Die andere Seite unseres Selbst. Nervenarzt 2016;87:1227-40. [DOI: 10.1007/s00115-016-0230-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 274 |
Moelling K, Broecker F. Fecal microbiota transplantation to fight Clostridium difficile infections and other intestinal diseases. Bacteriophage 2016;6:e1251380. [PMID: 28090385 DOI: 10.1080/21597081.2016.1251380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 275 |
Young VB. Therapeutic manipulation of the microbiota: past, present, and considerations for the future. Clin Microbiol Infect 2016;22:905-9. [PMID: 27619640 DOI: 10.1016/j.cmi.2016.09.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 276 |
Lübbert C. Fäkale Mikrobiotatransplantation (FMT). Diabetologe 2016;12:409-419. [DOI: 10.1007/s11428-016-0125-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 277 |
Wang S, Xu M, Wang W, Cao X, Piao M, Khan S, Yan F, Cao H, Wang B. Systematic Review: Adverse Events of Fecal Microbiota Transplantation. PLoS One. 2016;11:e0161174. [PMID: 27529553 DOI: 10.1371/journal.pone.0161174] [Cited by in Crossref: 200] [Cited by in F6Publishing: 224] [Article Influence: 28.6] [Reference Citation Analysis]
|
| 278 |
Evrensel A, Ceylan ME. Fecal Microbiota Transplantation and Its Usage in Neuropsychiatric Disorders. Clin Psychopharmacol Neurosci 2016;14:231-7. [PMID: 27489376 DOI: 10.9758/cpn.2016.14.3.231] [Cited by in Crossref: 87] [Cited by in F6Publishing: 94] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 279 |
Martins FS. Fecal Microbiota Transplantation for Ulcerative Colitis: FoMenTing Change? Dig Dis Sci 2016;61:2154-5. [PMID: 27003147 DOI: 10.1007/s10620-016-4133-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 280 |
Xu L, Zhang T, Cui B, He Z, Xiang J, Long C, Peng Z, Li P, Huang G, Ji G, Zhang F. Clinical efficacy maintains patients' positive attitudes toward fecal microbiota transplantation. Medicine (Baltimore) 2016;95:e4055. [PMID: 27472679 DOI: 10.1097/MD.0000000000004055] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 281 |
Zhang T, Cui B, Li P, He Z, Long C, Wei L, Peng Z, Ji G, Zhang F. Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis. PLoS One 2016;11:e0158227. [PMID: 27347881 DOI: 10.1371/journal.pone.0158227] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 282 |
Ericsson AC, Franklin CL. Manipulating the Gut Microbiota: Methods and Challenges. ILAR J 2015;56:205-17. [PMID: 26323630 DOI: 10.1093/ilar/ilv021] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 283 |
Shi Y, Dong Y, Huang W, Zhu D, Mao H, Su P. Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS One. 2016;11:e0157259. [PMID: 27295210 DOI: 10.1371/journal.pone.0157259] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 284 |
Spinler JK, Ross CL, Savidge TC. Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for? Anaerobe 2016;41:51-7. [PMID: 27180657 DOI: 10.1016/j.anaerobe.2016.05.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 285 |
Sbahi H, Di Palma JA. Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol 2016;3:e000087. [PMID: 27239328 DOI: 10.1136/bmjgast-2016-000087] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 286 |
Antonopoulos DA, Chang EB. Transplanting a Microbial Organ: the Good, the Bad, and the Unknown. mBio 2016;7:e00572-16. [PMID: 27143392 DOI: 10.1128/mBio.00572-16] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 287 |
Shin JH, Chaves-olarte E, Warren CA. Clostridium difficileInfection. Emerging Infections 10 2016. [DOI: 10.1128/9781555819453.ch15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 288 |
Laszlo M, Ciobanu L, Andreica V, Pascu O. Fecal transplantation indications in ulcerative colitis. Preliminary study. Clujul Med 2016;89:224-8. [PMID: 27152073 DOI: 10.15386/cjmed-613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 289 |
Choi HH, Cho YS. Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc. 2016;49:257-265. [PMID: 26956193 DOI: 10.5946/ce.2015.117] [Cited by in Crossref: 155] [Cited by in F6Publishing: 162] [Article Influence: 22.1] [Reference Citation Analysis]
|
| 290 |
Cui B, Li P, Xu L, Peng Z, Xiang J, He Z, Zhang T, Ji G, Nie Y, Wu K, Fan D, Zhang F. Step-up fecal microbiota transplantation (FMT) strategy. Gut Microbes 2016;7:323-8. [PMID: 26939622 DOI: 10.1080/19490976.2016.1151608] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 291 |
Gupta S, Allen-Vercoe E, Petrof EO. Fecal microbiota transplantation: in perspective. Therap Adv Gastroenterol 2016;9:229-39. [PMID: 26929784 DOI: 10.1177/1756283X15607414] [Cited by in Crossref: 221] [Cited by in F6Publishing: 221] [Article Influence: 31.6] [Reference Citation Analysis]
|
| 292 |
Mullen KR, Yasuda K, Divers TJ, Weese JS. Equine faecal microbiota transplant: Current knowledge, proposed guidelines and future directions. Equine Vet Educ 2018;30:151-60. [PMID: 32313396 DOI: 10.1111/eve.12559] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 293 |
Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O'Sullivan JM. The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation. Front Cell Infect Microbiol 2016;6:15. [PMID: 26925392 DOI: 10.3389/fcimb.2016.00015] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 294 |
Ahuja NK, Ahuja A. Gastroenvironmental distress: metaphorical antecedents of the gut microbiome. Med Humanit 2016;42:121-7. [PMID: 26856356 DOI: 10.1136/medhum-2015-010784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 295 |
Borgia G, Maraolo AE, Foggia M, Buonomo AR, Gentile I. Fecal microbiota transplantation for Clostridium difficile infection: back to the future. Expert Opin Biol Ther. 2015;15:1001-1014. [PMID: 26063385 DOI: 10.1517/14712598.2015.1045872] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 296 |
Pevsner-fischer M, Rot C, Tuganbaev T, Elinav E. The Microbiota and Its Modulation in Immune-Mediated Disorders. Immune Rebalancing 2016. [DOI: 10.1016/b978-0-12-803302-9.00010-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 297 |
Almeida R, Gerbaba T, Petrof EO. Recurrent Clostridium difficile infection and the microbiome. J Gastroenterol 2016;51:1-10. [PMID: 26153514 DOI: 10.1007/s00535-015-1099-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 298 |
Dowle C. Faecal microbiota transplantation: a review of FMT as an alternative treatment forClostridium difficileinfection. Bioscience Horizons 2016;9:hzw007. [DOI: 10.1093/biohorizons/hzw007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 299 |
Vestal R. Fecal Microbiota Transplant. Hospital Medicine Clinics 2016;5:58-70. [DOI: 10.1016/j.ehmc.2015.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 300 |
Rao K, Safdar N. Fecal microbiota transplantation for the treatment of Clostridium difficile infection. J Hosp Med 2016;11:56-61. [PMID: 26344412 DOI: 10.1002/jhm.2449] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 301 |
Fuentes S, de Vos WM. How to Manipulate the Microbiota: Fecal Microbiota Transplantation. Adv Exp Med Biol 2016;902:143-53. [PMID: 27161356 DOI: 10.1007/978-3-319-31248-4_10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 302 |
Kahn SA, Kaplan JL. Fecal Microbial Transplant: For Whom, How, and When. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_35] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 303 |
Kirupananthan A. Transplanting fresh donor faeces to cure symptomatic relapsing Clostridium difficile infection: a literature review. Gastrointestinal Nursing 2015;13:48-54. [DOI: 10.12968/gasn.2015.13.10.48] [Reference Citation Analysis]
|
| 304 |
Øyri SF, Műzes G, Sipos F. Dysbiotic gut microbiome: A key element of Crohn's disease. Comp Immunol Microbiol Infect Dis 2015;43:36-49. [PMID: 26616659 DOI: 10.1016/j.cimid.2015.10.005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 305 |
Jia N. A Misleading Reference for Fecal Microbiota Transplant. Am J Gastroenterol 2015;110:1731. [PMID: 26673501 DOI: 10.1038/ajg.2015.305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 306 |
Zhang F, Zhu H. Reply to Jia. Am J Gastroenterol 2015;110:1731-2. [PMID: 26673500 DOI: 10.1038/ajg.2015.341] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 307 |
Bowman KA, Broussard EK, Surawicz CM. Fecal microbiota transplantation: current clinical efficacy and future prospects. Clin Exp Gastroenterol. 2015;8:285-291. [PMID: 26566371 DOI: 10.2147/ceg.s61305] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 308 |
Rao K, Young VB. Fecal microbiota transplantation for the management of Clostridium difficile infection. Infect Dis Clin North Am 2015;29:109-22. [PMID: 25677705 DOI: 10.1016/j.idc.2014.11.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 309 |
Pozhitkov AE, Leroux BG, Randolph TW, Beikler T, Flemmig TF, Noble PA. Towards microbiome transplant as a therapy for periodontitis: an exploratory study of periodontitis microbial signature contrasted by oral health, caries and edentulism. BMC Oral Health 2015;15:125. [PMID: 26468081 DOI: 10.1186/s12903-015-0109-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 310 |
Vincent Y, Manji A, Gregory-Miller K, Lee C. A Review of Management of Clostridium difficile Infection: Primary and Recurrence. Antibiotics (Basel) 2015;4:411-23. [PMID: 27025632 DOI: 10.3390/antibiotics4040411] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 311 |
Cui B, Li P, Xu L, Zhao Y, Wang H, Peng Z, Xu H, Xiang J, He Z, Zhang T, Nie Y, Wu K, Fan D, Ji G, Zhang F. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med. 2015;13:298. [PMID: 26363929 DOI: 10.1186/s12967-015-0646-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 103] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 312 |
Batista R, Kapel N, Megerlin F, Chaumeil J, Barbut F, Bourlioux P, Chast F. Le transfert de microbiote fécal lors d’infections récidivantes à Clostridium difficile. Cadre et aspects pharmacotechniques. Annales Pharmaceutiques Françaises 2015;73:323-31. [DOI: 10.1016/j.pharma.2015.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 313 |
Wen YL, Niu JK, Miao YL. Non-drug treatment of inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(23): 3720-3728 [DOI: 10.11569/wcjd.v23.i23.3720] [Reference Citation Analysis]
|
| 314 |
Malnick S, Melzer E. Human microbiome: From the bathroom to the bedside. World J Gastrointest Pathophysiol 2015; 6(3): 79-85 [PMID: 26301122 DOI: 10.4291/wjgp.v6.i3.79] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 315 |
Lübbert C, John E, von Müller L. Clostridium difficile infection: guideline-based diagnosis and treatment. Dtsch Arztebl Int. 2014;111:723-731. [PMID: 25404529 DOI: 10.3238/arztebl.2014.0723] [Cited by in Crossref: 12] [Cited by in F6Publishing: 31] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 316 |
Yan FY, Ju J, Gao F, Wang XQ. Application of fecal microbiota transplantation in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2015; 23(21): 3406-3412 [DOI: 10.11569/wcjd.v23.i21.3406] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 317 |
Edelstein CA, Kassam Z, Daw J, Smith MB, Kelly CR. The regulation of fecal microbiota for transplantation: An international perspective for policy and public health. Clinical Research and Regulatory Affairs 2015;32:99-107. [DOI: 10.3109/10601333.2015.1046602] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 318 |
Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A, Moore T, Wu G. Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook. Gastroenterology 2015;149:223-37. [PMID: 25982290 DOI: 10.1053/j.gastro.2015.05.008] [Cited by in Crossref: 380] [Cited by in F6Publishing: 395] [Article Influence: 47.5] [Reference Citation Analysis]
|
| 319 |
Abdul-Hai A, Abdallah A, Malnick SD. Influence of gut bacteria on development and progression of non-alcoholic fatty liver disease. World J Hepatol 2015;7:1679-84. [PMID: 26140087 DOI: 10.4254/wjh.v7.i12.1679] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 320 |
Aguirre M, Venema K. The art of targeting gut microbiota for tackling human obesity. Genes Nutr 2015;10:472. [PMID: 25991499 DOI: 10.1007/s12263-015-0472-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 321 |
Hirsch BE, Saraiya N, Poeth K, Schwartz RM, Epstein ME, Honig G. Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection. BMC Infect Dis 2015;15:191. [PMID: 25885020 DOI: 10.1186/s12879-015-0930-z] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 13.1] [Reference Citation Analysis]
|
| 322 |
Crum-Cianflone NF, Sullivan E, Ballon-Landa G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J Clin Microbiol 2015;53:1986-9. [PMID: 25878340 DOI: 10.1128/JCM.00820-15] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 323 |
Di Bella S, Gouliouris T, Petrosillo N. Fecal microbiota transplantation (FMT) for Clostridium difficile infection: Focus on immunocompromised patients. Journal of Infection and Chemotherapy 2015;21:230-237. [DOI: 10.1016/j.jiac.2015.01.011] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 324 |
Jarrad AM, Karoli T, Blaskovich MA, Lyras D, Cooper MA. Clostridium difficile drug pipeline: challenges in discovery and development of new agents. J Med Chem. 2015;58:5164-5185. [PMID: 25760275 DOI: 10.1021/jm5016846] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 325 |
Bourlioux P; workgroup of the French Academy of Pharmacy Faecal microbiota transplantation: Key points to consider. Ann Pharm Fr. 2015;73:163-168. [PMID: 25747146 DOI: 10.1016/j.pharma.2015.02.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 326 |
García-garcía-de-paredes A, Rodríguez-de-santiago E, Aguilera-castro L, Ferre-aracil C, López-sanromán A. Trasplante de microbiota fecal. Gastroenterología y Hepatología 2015;38:123-34. [DOI: 10.1016/j.gastrohep.2014.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 327 |
Scott KP, Antoine JM, Midtvedt T, van Hemert S. Manipulating the gut microbiota to maintain health and treat disease. Microb Ecol Health Dis. 2015;26:25877. [PMID: 25651995 DOI: 10.3402/mehd.v26.25877] [Cited by in Crossref: 85] [Cited by in F6Publishing: 117] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 328 |
Xu MQ, Cao HL, Wang WQ, Wang S, Cao XC, Yan F, Wang BM. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol 2015; 21(1): 102-111 [PMID: 25574083 DOI: 10.3748/wjg.v21.i1.102] [Cited by in CrossRef: 156] [Cited by in F6Publishing: 159] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 329 |
Cammarota G, Ianiro G, Cianci R, Bibbò S, Gasbarrini A, Currò D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy. Pharmacol Ther 2015;149:191-212. [PMID: 25561343 DOI: 10.1016/j.pharmthera.2014.12.006] [Cited by in Crossref: 115] [Cited by in F6Publishing: 121] [Article Influence: 14.4] [Reference Citation Analysis]
|
| 330 |
Walker AW. The Human Microbiota and Pathogen Interactions. Molecular Medical Microbiology. Elsevier; 2015. pp. 347-56. [DOI: 10.1016/b978-0-12-397169-2.00019-6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 331 |
Ohkusa T, Koido S. II. Fecal Microbiota Transplantation and Its Clinical Application. J Jpn Soc Intern Med 2015;104:42-47. [DOI: 10.2169/naika.104.42] [Reference Citation Analysis]
|
| 332 |
Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 2015;30:51-8. [PMID: 25168749 DOI: 10.1111/jgh.12727] [Cited by in Crossref: 207] [Cited by in F6Publishing: 211] [Article Influence: 25.9] [Reference Citation Analysis]
|
| 333 |
. Faecal microbiota transplantation. Drug Ther Bull 2014;52:141-4. [PMID: 25505015 DOI: 10.1136/dtb.2014.12.0298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 334 |
Allegretti JR, Korzenik JR, Hamilton MJ. Fecal microbiota transplantation via colonoscopy for recurrent C. difficile Infection. J Vis Exp 2014. [PMID: 25549239 DOI: 10.3791/52154] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 335 |
Kassam Z, Lee CH, Hunt RH. Review of the Emerging Treatment of Clostridium difficile Infection with Fecal Microbiota Transplantation and Insights into Future Challenges. Clinics in Laboratory Medicine 2014;34:787-98. [DOI: 10.1016/j.cll.2014.08.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 336 |
Dai YX, Shi CB, Cui BT, Wang M, Ji GZ, Zhang FM. Fecal microbiota transplantation and prednisone for severe eosinophilic gastroenteritis. World J Gastroenterol 2014; 20(43): 16368-16371 [PMID: 25473198 DOI: 10.3748/wjg.v20.i43.16368] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 337 |
Seufferlein T, Kleger A, Nitschmann S. [Recurrent Clostridium difficile infection. Treatment with duodenal infusion of donor feces]. Internist (Berl) 2014;55:455-9. [PMID: 24647687 DOI: 10.1007/s00108-014-3483-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 338 |
Guo WT, Dong LN, Wang JP, Liu P. New advances in clinical application of fecal microbiota transplantation. Shijie Huaren Xiaohua Zazhi 2014; 22(30): 4593-4598 [DOI: 10.11569/wcjd.v22.i30.4593] [Reference Citation Analysis]
|
| 339 |
Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20(40): 14805-14820 [PMID: 25356041 DOI: 10.3748/wjg.v20.i40.14805] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 79] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 340 |
Megerlin F, Fouassier E. Le transfert de microbiote intestinal à finalité thérapeutique : quel droit applicable en France ? Annales Pharmaceutiques Françaises 2014;72:363-74. [DOI: 10.1016/j.pharma.2014.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 341 |
Borody TJ, Finlayson S. Fecal microbiota transplantation for Clostridium difficile infection: A surgeon׳s perspective. Seminars in Colon and Rectal Surgery 2014;25:163-166. [DOI: 10.1053/j.scrs.2014.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 342 |
de Vos W. Fame and Future of Fecal Transplantations: Developing Next-Generation Therapies with Synthetic Microbiomes. Health and the Gut 2014. [DOI: 10.1201/b17254-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 343 |
Huertas M, Michán C. Gut Microbiota: In Sickness and in Health. Health and the Gut 2014. [DOI: 10.1201/b17254-5] [Reference Citation Analysis]
|
| 344 |
Brown WR. Fecal microbiota transplantation in treating Clostridium difficile infection. J Dig Dis 2014;15:405-8. [PMID: 24825534 DOI: 10.1111/1751-2980.12160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 345 |
Borody TJ, Peattie D, Kapur A. Could fecal microbiota transplantation cure all Clostridium difficile infections? Future Microbiol. 2014;9:1-3. [PMID: 24328373 DOI: 10.2217/fmb.13.146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 346 |
Megerlin F, Fouassier E, Lopert R, Bourlioux P. Faecal microbiota transplantation: A sui generis biological drug, not a tissue. Annales Pharmaceutiques Françaises 2014;72:217-20. [DOI: 10.1016/j.pharma.2014.04.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 347 |
Missaghi B, Barkema HW, Madsen KL, Ghosh S. Perturbation of the human microbiome as a contributor to inflammatory bowel disease. Pathogens 2014;3:510-27. [PMID: 25438009 DOI: 10.3390/pathogens3030510] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 348 |
Barbut F, Collignon A, Butel MJ, Bourlioux P. [Fecal microbiota transplantation: review]. Ann Pharm Fr 2015;73:13-21. [PMID: 25577013 DOI: 10.1016/j.pharma.2014.05.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 349 |
Mir S, Kellermayer R, Gulati AS. Pediatric Fecal Microbiota Transplantation. Curr Pediatr Rep 2014;2:227-34. [DOI: 10.1007/s40124-014-0049-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 350 |
Nieuwdorp M. Faecal microbiota transplantation. Br J Surg 2014;101:887-8. [PMID: 24844698 DOI: 10.1002/bjs.9549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 351 |
Sha S, Liang J, Chen M, Xu B, Liang C, Wei N, Wu K. Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children. Aliment Pharmacol Ther 2014;39:1003-32. [PMID: 24641570 DOI: 10.1111/apt.12699] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 352 |
Petrof EO, Khoruts A. From stool transplants to next-generation microbiota therapeutics. Gastroenterology 2014;146:1573-82. [PMID: 24412527 DOI: 10.1053/j.gastro.2014.01.004] [Cited by in Crossref: 139] [Cited by in F6Publishing: 143] [Article Influence: 15.4] [Reference Citation Analysis]
|
| 353 |
Cammarota G, Ianiro G, Bibbò S, Gasbarrini A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med. 2014;9:365-373. [PMID: 24664520 DOI: 10.1007/s11739-014-1069-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 354 |
Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep. 2013;15:337. [PMID: 23852569 DOI: 10.1007/s11894-013-0337-1] [Cited by in Crossref: 160] [Cited by in F6Publishing: 138] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 355 |
Mccune V, Struthers J, Hawkey P. Faecal transplantation for the treatment of Clostridium difficile infection: a review. International Journal of Antimicrobial Agents 2014;43:201-6. [DOI: 10.1016/j.ijantimicag.2013.10.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 356 |
Fuentes S, van Nood E, Tims S, Heikamp-de Jong I, ter Braak CJ, Keller JJ, Zoetendal EG, de Vos WM. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J. 2014;8:1621-1633. [PMID: 24577353 DOI: 10.1038/ismej.2014.13] [Cited by in Crossref: 138] [Cited by in F6Publishing: 139] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 357 |
Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I. Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10 years? World J Gastroenterol 2014; 20(5): 1192-1210 [PMID: 24574795 DOI: 10.3748/wjg.v20.i5.1192] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 254] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 358 |
Moayyedi P, Marshall JK, Yuan Y, Hunt R. Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy. Can J Gastroenterol Hepatol 2014;28:66-8. [PMID: 25232572 DOI: 10.1155/2014/346590] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 359 |
Valiquette L, Laupland KB. Something old, something new, something borrowed... Can J Infect Dis Med Microbiol 2013;24:63-4. [PMID: 24421800 DOI: 10.1155/2013/514130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 360 |
Huertas MJ, Michán C. Gut microbiota: in sickness and in health. Microb Biotechnol 2014;7:88-9. [PMID: 24387339 DOI: 10.1111/1751-7915.12106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 361 |
König J, Brummer R. Modulation of the Gut Ecosystem in Irritable Bowel Syndrome. Pharma-Nutrition 2014. [DOI: 10.1007/978-3-319-06151-1_4] [Reference Citation Analysis]
|
| 362 |
Borody TJ, Brandt LJ, Paramsothy S. Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol 2014;30:97-105. [PMID: 24257037 DOI: 10.1097/MOG.0000000000000027] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 363 |
Dodin M, Katz DE. Faecal microbiota transplantation for Clostridium difficile infection. Int J Clin Pract 2014;68:363-8. [DOI: 10.1111/ijcp.12320] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 364 |
Fumery M, Corcos O, Kapel N, Stefanescu C, Thomas M, Joly F. Intérêt et technique de la transplantation fécale. Journal des Anti-infectieux 2013;15:187-192. [DOI: 10.1016/j.antinf.2013.10.002] [Reference Citation Analysis]
|
| 365 |
Kellermayer R. Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disorders. World J Gastrointest Pathophysiol 2013; 4(4): 91-93 [PMID: 24244876 DOI: 10.4291/wjgp.v4.i4.91] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 366 |
Zhang FM, Wang HG, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn’s disease. World J Gastroenterol 2013; 19(41): 7213-7216 [PMID: 24222969 DOI: 10.3748/wjg.v19.i41.7213] [Cited by in CrossRef: 84] [Cited by in F6Publishing: 94] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 367 |
Smits LP, Bouter KE, de Vos WM, Borody TJ, Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013;145:946-53. [PMID: 24018052 DOI: 10.1053/j.gastro.2013.08.058] [Cited by in Crossref: 421] [Cited by in F6Publishing: 432] [Article Influence: 42.1] [Reference Citation Analysis]
|
| 368 |
Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013;13:790-801. [PMID: 24096337 DOI: 10.1038/nri3535] [Cited by in Crossref: 917] [Cited by in F6Publishing: 923] [Article Influence: 91.7] [Reference Citation Analysis]
|
| 369 |
Koenigsknecht MJ, Young VB. Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs. Curr Opin Gastroenterol 2013;29:628-32. [PMID: 24100717 DOI: 10.1097/MOG.0b013e328365d326] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 370 |
Cui BT, Wang M, Ji GZ, Fan ZN, Zhang FM. Fecal microbiota transplantation: from the 4th century to 2013. Shijie Huaren Xiaohua Zazhi 2013; 21(30): 3222-3229 [DOI: 10.11569/wcjd.v21.i30.3222] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 371 |
Wang H, Wang M, Fan Z, Ji G, Zhang F. Possible primary immunodeficiency presenting with gastrointestinal symptoms: Case report and minireview. Exp Ther Med 2013;6:616-8. [PMID: 24137237 DOI: 10.3892/etm.2013.1178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 372 |
Vindigni SM, Broussard EK, Surawicz CM. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Rev Gastroenterol Hepatol 2013;7:615-28. [PMID: 24070153 DOI: 10.1586/17474124.2013.832501] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 373 |
Orenstein R, Griesbach CL, DiBaise JK. Moving fecal microbiota transplantation into the mainstream. Nutr Clin Pract 2013;28:589-98. [PMID: 23979974 DOI: 10.1177/0884533613497516] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 374 |
Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc 2013;78:240-9. [PMID: 23642791 DOI: 10.1016/j.gie.2013.03.1329] [Cited by in Crossref: 162] [Cited by in F6Publishing: 178] [Article Influence: 16.2] [Reference Citation Analysis]
|
| 375 |
de Vos WM. Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes. Microb Biotechnol. 2013;6:316-325. [PMID: 23574632 DOI: 10.1111/1751-7915.12047] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 376 |
de Vos WM. Fame and future of faecal transplantations--developing next-generation therapies with synthetic microbiomes. Microb Biotechnol. 2013;6:316-325. [PMID: 23574632 DOI: 10.1111/1751-7915] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
|
| 377 |
Brandt LJ. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol 2013;108:177-85. [PMID: 23318479 DOI: 10.1038/ajg.2012.450] [Cited by in Crossref: 128] [Cited by in F6Publishing: 134] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 378 |
Vrieze A, de Groot PF, Kootte RS, Knaapen M, van Nood E, Nieuwdorp M. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best Pract Res Clin Gastroenterol 2013;27:127-37. [PMID: 23768558 DOI: 10.1016/j.bpg.2013.03.003] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 7.2] [Reference Citation Analysis]
|
